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a b s t r a c t
Based on the recent observation that the antiplatelet agent ticagrelor and one of its metabolite exert
bactericidal activity against gram-positive bacteria, a series of 1,2,3-triazolo[4,5-d]pyrimidines struc-
turally related to ticagrelor were synthesized and examined as putative antiplatelet and antibacterial
agents. The aim was to assess the possibility of dissociating the two biological properties and to !nd
novel 1,2,3-triazolo[4,5-d]pyrimidines expressing antiplatelet activity and devoid of in vitro antibacterial
activity. The new compounds synthesized were known metabolites of ticagrelor as well as structurally
simpli!ed analogues. Some of them were found to express antiplatelet activity and to lose the anti-
bacterial activity, supporting the view that the two activities were not necessarily linked.
© 2020 Elsevier Masson SAS. All rights reserved.
1. Introduction
Ticagrelor (1; Fig. 1) is an orally active antiplatelet drug
belonging to 1,2,3-triazolo[4,5-d]pyrimidines (8-azapurines),
which acts by reversibly inhibiting the platelet P2Y12 receptor for
ADP in a noncompetitive manner [1,2]. This drug used in human
medicine was developed to improve the ef!cacy and circumvent
the limitations of the !rst-generation P2Y12 inhibitors [3,4].
Although ticagrelor doesn’t need to be metabolized to be active
in vivo, this drug is known to be extensively metabolized via cy-
tochrome P450 3A4 and 3A5 to form a main metabolite known as
AR-C124910, representing approximately one third of ticagrelor in
the circulation [5]. Ticagrelor and its main metabolite inhibit P2Y12
receptors with equivalent potency [5]. Recently, we observed that
ticagrelor and its active metabolite AR-124910 also exert in vitro
bactericidal activity against Gram-positive strains, including
antibiotic-resistant strains, such as Staphylococcus aureus, Staphy-
lococcus epidermidis and Enterococcus faecalis [6]. As a result, tica-
grelor might prove superior to other P2Y12 inhibitors in patients
with cardiovascular disease at risk for gram-positive bacterial in-
fections such as infective endocarditis [6]. Another well-known
additional bene!t of ticagrelor compared to other clinically used
P2Y12 inhibitors is also its ability to exert anti-in"ammatory ac-
tivity, notably by decreasing in"ammatory cytokines such as
interleukin 6 and tumor necrosis factor alpha as well as platelet-
leukocyte aggregates or by acting directly on endothelial cells,
independently of the P2Y12 receptor [7e11].
N7-substituted 7-amino-5-alkylsulfanyl-1,2,3-triazolo[4,5-d]py-
rimidines, among which the antiplatelet agent ticagrelor, are rela-
tively poorly described in the literature. Besides examples of P2Y12
receptor antagonists structurally related to ticagrelor [1,12], recent
publications also reported compounds of this chemical class
expressing antiproliferative activity [i.e. compound 2 [13]; com-
pound 3 [14]; compound 4 [15]; compound 5 [16]; i.e. compound 6,
identi!ed as a lysine speci!c demethylase 1 (LSD1) inhibitor [17];
Fig. 1]. No indication of antibacterial activity was reported for
compounds of this class until the recent discovery of the antibiotic
effect of ticagrelor on several Gram-positive bacterial strains.
The present work aims at establishing structure-activity re-
lationships in order to identify the structural elements responsible,
on the one hand, for the antiplatelet activity, and, on the other
hand, for the antibacterial activity of ticagrelor analogues i.e. some
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of its metabolites as well as simpli!ed structures (general formula,
see 7; Fig. 2).
2. Results and discussion
2.1. Chemistry
The synthesis of the target compounds (7; Fig. 2) is described in
Scheme 1. Several steps were adaptations of previously described
processes [12]. Starting from thiobarbituric acid (8), alkylation in
aqueous alkaline medium using an appropriate alkyl halide led to
the 2-alkylsulfanyl-substituted derivatives of general formula 9,
which in turn were converted into the corresponding 5-nitro-
substituted derivatives 10 after reaction with nitric acid in glacial
acetic acid. The latter compounds reacted with phosphorus oxy-
chloride in the presence of 2,6-lutidine to provide the corre-
sponding 4,6-dichloro-substituted compounds 11b. These
intermediates 11b, as well as the commercially available 2,4,6-
trichloro-substituted analogue 11a, were easily converted into the
corresponding 5-amino-substituted compounds 12a and 12b after
reduction in the presence of iron powder in a mixture of acetic acid
and methanol. The appropriate primary amine [R3-NH2: methyl-
amine, ethylamine, cyclopentylamine, (3aR,4S,6R,6aS)-6-amino-
2,2-dimethyltetrahydrocyclopenta[d][1,3]dioxol-4-ol and 2-
(((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclo-
penta[d][1,3]dioxol-4-yl)oxy)ethanol] was introduced at the 3-
position of intermediates 12a-b after nucleophilic substitution in
methanol of one chlorine atom linked to the ortho position of the
amine function. Ring closure reaction occurred after diazotization
in the presence of sodium nitrite and acetic acid to provide the
triazolo[4,5-d]pyrimidine intermediates 14a-c. Due to the
increased sensitivity of the 7-position of triazolo[4,5-d]pyrimidines
to nucleophilic substitution as a probable result of the vicinity of
the triazole ring, the chlorine atom at this position was easily
substituted with the appropriate alkyl/aralkylamine [R2-NH2;
cyclopropylamine, 3,4-di"uorophenethylamine, (1R,2S)-2-
phenylcyclopropylamine or (1R,2S)-2-(3,4-di"uorophenyl)cyclo-
propylamine] in acetonitrile in the presence of triethylamine,
leading to intermediates 15a-c. Strong nucleophiles such as thiols
were able to displace the last chlorine atom linked at the 5-position
of the triazolo[4,5-d]pyrimidine ring system giving access to com-
pounds of general formula 7. The !nal compounds bearing a pol-
yhydroxypentane group (compounds 7h-t) at the 3-position were
obtained after removal of the acetonide protecting group under
strong acidic conditions.
An interesting observation was made with the target com-
pounds bearing an aralkylamino group at the 7-position of the
1,2,3-triazolo[4,5-d]pyrimidine core structure. The 1H NMR spectral
data of these drugs recorded in DMSO!d6 always revealed the
presence of two groups of signals. This was particularly evident for
the N-H proton linked at the 7-position of the triazolopyrimidine
ring and for the C-H proton linked at the !rst carbon atom of the
cyclopropyl ring of (3,4-di"uorophenyl)cyclopropylamino-
substituted compounds (Table 2). Such an observation is in accor-





































































Fig. 1. Examples of N7-substituted 7-amino-5-alkylsulfanyl-1,2,3-triazolo[4,5-d]pyrimidines described in the literature (1: ticagrelor).
Fig. 2. General formula of the newly synthesized compounds.
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conformational isomers resulting from the rotation around the C8-
N1’ bond (Fig. 3) (also reported for azaadenine derivatives [18]), the
former isomers being the two preferred conformations assuming
an optimal delocalization of electrons in the planar “amidine”
system (numbering N7-C8-N1’ in Fig. 3). In accordance with the
planarity of the system, and for steric reasons, conformer B is ex-
pected to be the major form (estimation from NMR data in
DMSO!d6 at r.t.: 80% of conformer B versus 20% of conformer A). The
preference of the B conformation for ticagrelor (and for related
analogues) is con!rmed by crystallographic data obtained with the
antiplatelet agent (alone or in co-crystalisation) revealing the
presence of conformer B in the crystal lattices [19e21]. The
planarity of the “amidine” system was also con!rmed from the
crystallographic data obtained with ticagrelor alone providing a
torsion angle C9-C8-N1’-C1’ of 178.6!, thus not far fom the planarity
(180.0!) [20].
The attribution of the chemical shifts reported in Table 2 is
deduced from the in"uence of the proximity of the N1 nitrogen
atom, which is expected to induce a greater deshielding of the C-H
proton in the case of conformer A, and a greater deshielding of the
N-H proton in the case of conformer B.
Scheme 1. Synthesis of Ticagrelor Analogues Belonging to 1,2,3-Triazolo[4,5-d]pyrimidines.
Reagents and conditions: (i) R1X, KOH, water, 80 !C, sealed tube, 2 h; (ii) nitric acid, acetic acid, 0 !C to r.t., 1 h; (iii) POCl3, 2,6-lutidine, 0 !Ce80 !C, 2 h; (iv) iron powder, acetic acid,
methanol, r.t., 2 h; (v) R3NH2, methanol, 110 !C, sealed tube, 1 h; (vi) NaNO2, acetic acid, 0 !C to r.t., 2 h; (vii) R2NH2, TEA, acetonitrile, 80 !C, 1e4 h; (viii) R1SH, K2CO3, acetonitrile,
60e110 !C, 3 h; (ix) HCl, methanol, r.t., 30 min.
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2.2. Biological evaluation
Table 1 reports the biological results (antiplatelet and antibac-
terial activity) obtained with ticagrelor (1), several of its metabo-
lites (7i, 7n-t) and simpli!ed analogues of ticagrelor bearing a short
alkyl group at the 3-position and/or a short alkylsulfanyl group at
the 5-position and/or a simpli!ed aralkylamino group at the 7-
position (7a-h, 7j-m, 7u-v). The aim was to examine the anti-
platelet versus antibacterial activity of other known ticagrelor
metabolites as well as a series of original simpli!ed analogues.
The antiplatelet activity of the testedmolecules was analyzed by
light transmission aggregometry upon platelet stimulation with
ADP in citrated platelet-rich-plasma using a drug concentration
equal to ticagrelor IC50 (1.8 mM) (Fig. 4). The antibacterial activity
against methicillin-resistant Staphylococcus aureus (MRSA, ATCC
BAA-1556) was determined by the broth microdilution method as
recommended by EUCAST guidelines.
Only ticagrelor (1) and its main metabolite AR-C124910 (7i)
showed antibacterial activity against MRSA. The other compounds
revealed absence of activity against bacteria up to a concentration
Conformer A           Conformer B
Fig. 3. Conformational isomerism resulting from the rotation around the C8-N1’ bond
of N7-substituted 7-amino-1,2,3-triazolo[4,5-d]pyrimidines.
Table 1
Antiplatelet activity of 1,2,3-triazolo[4,5-d]pyrimidines structurally related to ticagrelor; antibacterial activity established on methicillin-resistant S. aureus.
Cpd -X -R2 -R3 Antiplatelet activity (Fold-inhibition vs vehiclea) Antibacterial activity (MICb, mM)
7a -SCH3 -CH(CH2)CH-C6H3F2 -CH3 0.94 ± 0.09 >200
7b -SCH3 -CH(CH2)CH-C6H3F2 -CH2CH3 0.87 ± 0.04 >200
7c -SCH2CH3 -CH(CH2)CH-C6H3F2 -CH3 0.97 ± 0.08 >200
7d -SCH2CH3 -CH(CH2)CH-C6H3F2 -CH2CH3 0.91 ± 0.15 >200
7e -SCH2CH2CH3 -CH(CH2)CH-C6H3F2 -CH3 1.08 ± 0.05 >200
7f -SCH2CH2CH3 -CH(CH2)CH-C6H3F2 -CH2CH3 0.97 ± 0.06 >200
7g -SCH2CH2CH3 -CH(CH2)CH-C6H3F2 -C5H9 1.00 ± 0.09 >200
7h -SCH2CH2CH3 H -C5H6(OH)3 1.10 ± 0.09 >200
7i -SCH2CH2CH3 -CH(CH2)CH-C6H3F2 -C5H6(OH)3 4.80 ± 2.50# 25
7j -SCH2CH2CH3 H -C5H6(OH)2OCH2CH2OH 1.10 ± 0.13 >200
7k -SCH2CH2CH3 -CH(CH2)2 -C5H6(OH)2OCH2CH2OH 2.60 ± 0.65 >200
7l -SCH2CH2CH3 -CH(CH2)CH-C6H5 -C5H6(OH)2OCH2CH2OH 3.10 ± 0.65# >200
7m -SCH2CH2CH3 -CH2CH2-C6H3F2 -C5H6(OH)2OCH2CH2OH 1.10 ± 0.07 >200
1 -SCH2CH2CH3 -CH(CH2)CH-C6H3F2 -C5H6(OH)2OCH2CH2OH 4.30 ± 2.20# 25
7n -SCH2CH(OH)CH3 H -C5H6(OH)3 1.00 ± 0.17 >200
7o -SCH2CH2CH2OH H -C5H6(OH)3 1.00 ± 0.09 >200
7p -SCH2CH2CH2OH -CH(CH2)CH-C6H3F2 -C5H6(OH)3 2.70 ± 0.99*# >200
7q ReSCH2CH(OH)CH3 -CH(CH2)CH-C6H3F2 -C5H6(OH)3 6.20 ± 3.70# >200
7r S-SCH2CH(OH)CH3 -CH(CH2)CH-C6H3F2 -C5H6(OH)3 2.00 ± 0.72# >200
7s -SCH2CH(OH)CH3 -CH(CH2)CH-C6H3F2 -C5H6(OH)2OCH2CH2OH 1.70 ± 0.24 >200
7t -SCH2CH2CH2OH -CH(CH2)CH-C6H3F2 -C5H6(OH)2OCH2CH2OH 1.00 ± 0.02 >200
7u -H -CH(CH2)CH-C6H3F2 -C5H6(OH)3 1.00 ± 0.04 >200
7v -Cl -CH(CH2)CH-C6H3F2 -C5H6(OH)3 1.10 ± 0.12 >200
a Vehicle: 1% DMSO.
b MIC: minimal inhibitory concentration. Antiplatelet activity is presented as fold-inhibition vs. vehicle of area under the curve values of ADP-induced platelet aggregation
(mean ± S.D., n " 4e21). # indicates P < 0.05 vs. vehicle; * indicates P < 0.05 vs. antiplatelet activity of compound 1 (wilcoxon matched-pairs signed rank test).
Table 2
1H NMR Chemical Shifts (in ppm) Attributed to the C-H Proton (Ha or Ha’) Linked to
the First Cyclopropyl Carbon Atom and to the N-H Proton (Hb or Hb’) at the 7-Position
of the 1,2,3-Triazolo[4,5-d]pyrimidine Ring.
Cmpd -X -R3 C-H N-H
Ha Ha’ Hb Hb’
7a -SCH3 -CH3 3.76 3.15 8.96 9.34
7d -SCH2CH3 -CH2CH3 3.77 3.16 8.96 9.37
7i -SCH2CH2CH3 -C5H6(OH)3 3.78 3.16 8.93 9.35
1 -SCH2CH2CH3 -C5H6(OH)2OCH2CH2OH 3.79 3.16 8.94 9.36
7u -H -C5H6(OH)3 3.82 3.29 9.04 9.34
7v -Cl -C5H6(OH)3 3.82 3.14 9.53 9.81
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of 200 mM. On the contrary, !ve ticagrelor analogues (7i, 7l, 7p, 7q,
7r), among which the active metabolite AR-C124910 (7i), displayed
antiplatelet activity. The antiplatelet activity of molecules 7i, 7l, 7q
and 7rwas similar to that of the reference compound 1while it was
weaker than the reference compound for molecule 7p (P " 0.016).
Interestingly, the antiplatelet activity of the R-isomer 7q was
found to be more pronounced than that of its counterpart, the S-
isomer 7r (P " 0.03), both of them being possible metabolites of
ticagrelor and resulting from the hydroxylation at the 2-position of
the propylsulfanyl side chain of the active metabolite 7i [22]. Hy-
droxylation at the 3-position of the same side chain of 7i also
provided another known metabolite [22], compound 7p, which
also showed antiplatelet activity.
The antiplatelet activity, but not the antibacterial activity, was
maintained when the nature of the aralkylamino side chain at the
7-position was simpli!ed. The ticagrelor analogue 7l devoid of the
two "uorine atoms at the 3,4-positions of the phenyl ring was
equipotent to the reference compound 1. The presence of a single
cyclopropyl chain instead of a phenylcyclopropyl moiety (com-
pound 7k) was suf!cient to maintain a marked antiplatelet activity.
Surprisingly, the replacement of the cyclopropyl group of 1with an
ethylene moiety (compound 7m) dramatically suppressed the an-
tiplatelet activity. The absence of the aralkyl group on the nitrogen
atom at the 7-position of 1 (providing compound 7j) also generated
the similar results.
3. Conclusion
A series of 1,2,3-triazolo[4,5-d]pyrimidines structurally related
to ticagrelor were synthesized and examined as putative anti-
platelet and antibacterial agents. Slight modi!cations of the
structure of ticagrelor dramatically led to a loss of the antibacterial
activity against methicillin-resistant Staphylococcus aureus, while
the antiplatelet activity was maintained with some simpli!ed
ticagrelor analogues. Our results indicated that the antiplatelet and
antibacterial activity of 1,2,3-triazolo[4,5-d]pyrimidines were not
necessarily linked supporting the view that the observed effects
involve distinct mechanisms and unrelated biological targets.
4. Experimental section
4.1. General procedures
Melting points were determined on a Stuart SMP3 capillary
apparatus and are uncorrected. The 1H and 13C NMR spectra were
recorded on Bruker instruments equipped with a TCI cryoprobe
(Bruker Avance HD 500MHz for 1H; 125MHz for 13C/Bruker Avance
III HD 700 MHz for 1H; 176 MHz for 13C) using deuterated dimethyl
sulfoxide (DMSO!d6) or deuterated chloroform (CDCl3) as the sol-
vent with tetramethylsilane (TMS) as an internal standard; chem-
ical shifts are reported in d values (ppm) relative to that of internal
TMS. The abbreviations s " singlet, d " doublet, t " triplet,
q " quadruplet, p " pentuplet, h " hexuplet, m " multiplet,
dd " doublet of doublet, td " triplet of doublet, qd " quadruplet of
doublet, dt " doublet of triplet, dq " doublet of quadruplet,
tt " triplet of triplet, tq " triplet of quadruplet, ddd " doublet of
doublet of doublets, ddt " doublet of doublet of triplets and
bs" broad singlet are used throughout. The compounds bearing an
aralkylamino group at the 7-position shows existence of two
isomeric forms, resulting in the duplication of several proton sig-
nals described as major and minor in the NMR data. Elemental
analyses (C, H, N, S) were realized on a Thermo Scienti!c Flash EA
1112 elemental analyzer and were within ±0.4% of the theoretical
values for carbon, hydrogen and nitrogen; a higher tolerance
(±0.75%) was admitted for sulfur, considering its corresponding
peak shape. This analytical method certi!ed a purity of #95% for
each tested compound. All reactions were routinely checked by TLC
on silica gel Merck 60 F254.
4.2. Materials
2-Thiobarbituric acid 8, 4,6-dichloro-2-(propylthio)pyrimidin-
5-amine 12b.3 (R1 " propyl), 4,6-dichloropyrimidin-5-amine 12c,
2,4,6-trichloro-5-nitropyrimidine 11a, (1R,2S)-2-(3,4- di"uor-
ophenyl)cyclopropanamine and 2-(((3aR,4S,6R,6aS)-6-amino-2,2-
dimethyltetrahydro- 3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)
ethanol were purchased from Fluorochem. (3aR,4S,6R,6aS)-6-
Amino-2,2-dimethyltetrahydrocyclopenta[d][1,3]dioxol-4-ol was
purchased from Spirochem. 3-mercapto-1-propanol and 1-
mercaptopropan-2-ol were purchased from Aldrich. Both enan-
tiomers of 1-mercaptopropan-2-ol were purchased from
Chemspace.
4.3. 2-(Methylthio)pyrimidine-4,6-diol (9.1)
2-Thiobarbituric acid 8 (2,50 g, 17.4 mmol) was dissolved in KOH
10% (25 mL) and supplemented with methyl iodide (1.25 mL,
20.0 mmol). The reaction mixture was introduced in a sealed vessel
and heated at 80 !C for 1 h. After cooling on an ice bath to 5 !C, the
mixture was acidi!ed by addition of hydrochloric acid 6 N and the
resulting precipitate was !ltered off and washed with diethyl ether
to give 9.1 (2,10 g, 77% yield, m.p.: >300 !C). 1H NMR (DMSO!d6):
d 2.46 (s, 3H, SCH 3), 5.13 (s, 1H, CH), 11.71 (bs, 2H, OH). 13C NMR
(DMSO!d6): d 12.7, 85.5, 158.6, 163.5.
4.4. 2-(Ethylthio)pyrimidine-4,6-diol (9.2)
2-Thiobarbituric acid 8 (2.50 g, 17.4 mmol) was dissolved in KOH
10% (25 mL) and supplemented with ethyl iodide (1.63 mL,
20.0 mmol). The reaction mixture was introduced in a sealed vessel
and heated at 80 !C for 1 h. After cooling on an ice bath to 5 !C, the
mixture was acidi!ed by addition of hydrochloric acid 6 N and the
resulting precipitate was !ltered off and washed with diethyl ether
to give 9.2 (2.05 g, 69% yield, m.p.: >300 !C). 1H NMR (DMSO!d6):
Fig. 4. Representative ADP-induced platelet aggregation curves performed in human
citrated PRP after 10-min pre-incubation with the indicated molecules (1.8 mM) or
vehicle (1% DMSO). The arrow depicts the time of agonist addition.
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d 1.28 (t, J " 7.3 Hz, 3H, CH3), 3.08 (q, J " 7.3 Hz, 2H, SCH 2), 5.12 (s,
1H, CH), 11.68 (bs, 2H, OH). 13C NMR (DMSO!d6): d 14.6, 24.0, 85.6,
158.1, 162.8.
4.5. 2-(Methylthio)-5-nitropyrimidine-4,6-diol (10.1)
To 6 mL of acetic acid cooled at 5 !C on an ice bath were added
fuming nitric acid (2.5 mL) and (9.1) (2.0 g, 12.6 mmol). After 1 h
stirring at room temperature, the mixture was cooled at 5 !C on an
ice bath, water (50mL) was added and the resulting precipitatewas
!ltered off to give 10.1 (1,72 g, 67% yield, m.p.: 220e221 !C (dec.)).
1H NMR (DMSO!d6) d 2.56 (s, 3H, SCH 3). 13C NMR (DMSO!d6) d 13.2,
117.4, 158.7, 164.6.
4.6. 2-(Ethylthio)-5-nitropyrimidine-4,6-diol (10.2)
To 6 mL of acetic acid cooled at 5 !C on an ice bath were added
fuming nitric acid (2.5 mL) and (9.2) (1.80 g, 10.5 mmol). After 1 h
stirring at room temperature, the mixture was cooled at 5 !C on an
ice bath, water (50mL) was added and the resulting precipitatewas
!ltered off to give 10.2 (1.57 g, 69% yield, m.p.: 210e213 !C (dec.)).
1H NMR (DMSO!d6): d 1.31 (t, J " 7.3 Hz, 3H, CH3), 3.17 (q, J" 7.3 Hz,
2H, SCH 2). 13C NMR (DMSO!d6): d 14.4, 24.7, 117.4, 158.9, 164.0.
4.7. 4,6-Dichloro-2-(methylthio)-5-nitropyrimidine (11b.1)
To a solution of (10.1) (1.5 g, 7.4mmol) in POCl3 (10mL) cooled at
5 !C on an ice bath was added dropwise 2,6-lutidine (2.5 mL). After
2 h stirring at 80 !C, the mixture was poured on crushed ice and the
resulting precipitate was !ltered off to give 11b.1 (1.63 g, 92% yield,
m.p.: 63e64 !C).1H NMR (DMSO!d6): d 2.56 (s, 3H, SCH 3). 13C NMR
(DMSO!d6): d 13.5, 149.0, 154.5, 166.1.
4.8. 4,6-Dichloro-2-(ethylthio)-5-nitropyrimidine (11b.2)
To a solution of (10.2) (1.5 g, 6.9 mmol) in POCl3 (10 mL) cooled
at 5 !C on an ice bath was added dropwise 2,6-lutidine (2.5 mL).
After 2 h stirring at 80 !C, the mixture was poured on crushed ice
and extracted with ethyl acetate (3 $ 50 mL). The organic layers
werewashed with water and with an aqueous saturated solution of
sodium hydrogenocarbonate and ethyl acetate was evaporated to
dryness under vacuum. The resulting oily residue 11b.2 (1.76 g, 85%
yield) was used without further puri!cation in the next step
(12b.2). 1H NMR (DMSO!d6) d 1.35 (t, J " 7.3 Hz, 3H, CH3), 3.18 (q,
J " 7.3 Hz, 2H, SCH 2). 13C NMR (DMSO!d6) d 14.0, 25.3, 149.1, 154.5,
165.4.
4.9. 2,4,6-Trichloropyrimidin-5-amine (12a)
To a solution of 2,4,6-trichloro-5-nitropyrimidine 11a (1.0 g,
4.38 mmol) in methanol (10 mL) and acetic acid (4 mL) was added
iron powder (1.0 g,17.9 mmol) under vigorous agitation. After 1 h at
room temperature, the mixture was diluted with methanol (30 mL)
and !ltered. The precipitate was washed with methanol (30 mL)
and the !ltrate was then concentrated under reduced pressure. The
residue was taken up with water (50 mL) and extracted with
dichloromethane (3 $ 50 mL). The combined organic layers were
dried over MgSO4, evaporated and puri!ed by column chroma-
tography on silica gel using hexane/ethyl acetate gradient to give
12a as a white solid (0.77 g, 89% yield, m.p.: 107e109 !C). 1H NMR
(CDCl3): d 4.51 (bs, 2H, NH2). 13C NMR (CDCl3): d 134.7, 145.1, 145.4.
4.10. 4,6-Dichloro-2-(methylthio)pyrimidin-5-amine (12b.1)
To a solution of (11b.1) (1.0 g, 4.2 mmol) in methanol (10 mL)
and acetic acid (4 mL) was added iron powder (1,07 g, 19.5 mmol).
After 1 h stirring at room temperature, ethyl acetate (50 mL) was
added and the suspension was !ltered. The !ltrate was washed
with water and with an aqueous saturated solution of sodium
hydrogenocarbonate and the organic layer was evaporated to
dryness under vacuum. Water was added on the residue and the
resulting precipitate was !ltered off to give 12b.1 (0.83 g, 95% yield,
m.p.: 105e108 !C). 1H NMR (DMSO!d6): d 2.45 (s, 3H, SCH 3), 5.90 (s,
2H, NH2). 13C NMR (DMSO!d6): d 13.8, 133.4, 143.7, 154.4.
4.11. 4,6-Dichloro-2-(ethylthio)pyrimidin-5-amine (12b.2.)
To a solution of (11b.2) (1.0 g, 3.9 mmol) in methanol (10 mL)
and acetic acid (4 mL) was added iron powder (1.07 g, 19.5 mmol).
After 1 h stirring at room temperature, ethyl acetate (50 mL) was
added and the suspension was !ltered. The !ltrate was washed
with water and with an aqueous saturated solution of sodium
hydrogenocarbonate and the organic layer was evaporated to
dryness under vacuum. Water was added on the residue and the
resulting precipitate was !ltered off to give 12b.2 (0.76 g, 86% yield,
m.p.: 48e50 !C). 1H NMR (DMSO!d6): d 1.28 (t, J " 7.3 Hz, 3H, CH3),
3.02 (q, J " 7.3 Hz, 2H, SCH 2), 5.90 (s, 2H, NH2). 13C NMR
(DMSO!d6): d 14.3, 24.9, 133.5, 143.7, 153.8.
4.12. (3aR,4S,6R,6aS)-6-[(5-amino-6-chloropyrimidin-4-yl)amino]-
2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol (13c.1)
The mixture of 4,6-dichloropyrimidin-5-amine (1.0 g,
6.1 mmol), (3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro
cyclopenta[d][1,3]dioxol-4-ol (1.34 g, 7.8 mmol) and triethylamine
(0.85 mL, 6.1 mmol) in acetonitrile (10 mL) was placed in a sealed
vessel and heated overnight at 110 !C. After evaporation of the
solvent, the residue was puri!ed by column chromatography on
silica gel using 100% ethyl acetate to give 13c.1 as a white solid
(1.43 g, 78% yield). 1H NMR (DMSO!d6): d 1.21 (s, 3H, CH3), 1.36 (s,
3H, CH3), 1.70 (d, J" 13.7 Hz,1H, 50-Ha), 2.22 (m,1H, 50-Hb), 4.07 (m,
1H, 40-H), 4.29 (t, J " 5.9 Hz, 1H, 60-H), 4.41 (d, J" 6.0 Hz, 1H, 3a0-H),
4.51 (d, J " 6.0 Hz, 1H, 6a0-H), 4.97 (s, 2H, NH2), 5.25 (d, J " 3.1 Hz,
1H, OH), 6.49 (d, J " 7.2 Hz, 1H, NH), 7.79 (s, 1H, 2-H). 13C NMR





The mixture of 2,4,6-trichloropyrimidin-5-amine 12a (1.0 g,
5.0 mmol), (3aR,4S,6R,6aS)-6- amino-2,2-
dimethyltetrahydrocyclopenta[d][1,3]dioxol-4-ol (1.1 g, 6.4 mmol)
and triethylamine (0.7 mL, 5.0 mmol) in acetonitrile (10 mL) was
placed in a sealed vessel and heated overnight at 110 !C. After
evaporation of the solvent, the residue was puri!ed by column
chromatography on silica gel using 100% ethyl acetate to give 13a.1
as a white solid (1.48 g, 88% yield, m.p.: 105 !C (dec.)). 1H NMR
(CDCl3): d 1.29 (s, 3H, CH3), 1.45 (s, 3H, CH3), 1.82 (d, J " 14.5 Hz, 1H,
50-Ha), 2.17 (d, J " 2.0 Hz, 1H, OH), 2.36 (dt, J " 14.5 Hz/5.2 Hz, 1H,
50-Hb), 3.28 (s, 2H, NH2), 4.40 (d, J " 2.0 Hz, 1H, 40-H), 4.54 (d,
J " 5.3 Hz, 1H, 3a0-H), 4.57 (d, J " 5.3 Hz, 1H, 6a0-H), 4.71 (dd,
J " 8.4 Hz/6.6 Hz, 1H, 60-H), 6.11 (d, J " 8.7 Hz, 1H, NH). 13C NMR
(CDCl3): d 23.8, 26.2, 35.0, 57.0, 78.1, 85.2, 86.1, 110.6, 120.3, 142.8,
150.2, 155.1.




The mixture of 2,4,6-trichloropyrimidin-5-amine 12a (1.0 g,
5.0 mmol), 2-(((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-
3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol (1.4 g, 6.4 mmol)
and triethylamine (0.7 mL, 5.0 mmol) in acetonitrile (10 mL) was
placed in a sealed vessel and heated overnight at 110 !C. After
evaporation of the solvent, the residue was puri!ed by column
chromatography on silica gel using 100% ethyl acetate to give 13a.2
as an oily residue (1.59 g, 83% yield). 1H NMR (DMSO!d6): d 1.23 (s,
3H, CH3), 1.39 (s, 3H, CH3), 1.86 (d, J " 14.0 Hz, 1H, 50-Ha), 2.22 (m,
1H, 5‘-Hb), 3.51 (m, 4H, OCH2CH2OH), 3.90 (s, 1H, 4’-H), 4.30 (s, 1H,
60-H), 4.50 (s, 1H, 6a0-H), 4.54 (s, 1H, 3a0-H), 5.04 (s, 1H, OCH2-
CH2OH), 5.17 (s, 2H, NH2), 6.83 (d, J " 6.7 Hz, 1H, NH). 13C NMR
(DMSO!d6): d 24.1, 26.3, 32.9, 56.6, 60.3, 70.3, 83.2, 83.5, 83.9, 110.2,
112.8, 136.5, 144.6, 152.7.
4.15. 6-Chloro-N4-methyl-2-(methylthio)pyrimidine-4,5-diamine
(13b.1)
4,6-Dichloro-2-(methylthio)pyrimidin-5-amine (12b.1) (0.5 g,
2.4 mmol) was dissolved in methanol (2 mL) and supplemented
with a solution of methylamine 33% w/w in methanol (0.87 mL,
7.2 mmol). The reaction mixture was introduced in a sealed vessel
and heated at 100 !C for 1 h. After concentration of the reaction
mixture to dryness under vacuum, the residuewas puri!ed by silica
gel column chromatography to give 13b.1 (0.4 g, 82% yield, m.p.:
141e143 !C). 1H NMR (DMSO!d6): d 2.38 (s, 3H, SCH 3), 2.88 (d,
J " 3.0 Hz, 3H, NHCH3), 4.70 (s, 2H, NH2), 7.01 (s, 1H, NH). 13C NMR
(DMSO!d6): d 13.5, 27.8, 120.1, 137.2, 153.3, 155.9.
4.16. 6-Chloro-N4-ethyl-2-(methylthio)pyrimidine-4,5-diamine
(13b.2)
4,6-Dichloro-2-(methylthio)pyrimidin-5-amine (12b.1) (0.5 g,
2.4 mmol) was dissolved in a solution of ethylamine 2.0 M in
methanol (3.6 mL, 7.2 mmol). The reaction mixture was introduced
in a sealed vessel and heated at 100 !C for 1 h. After concentration
of the reaction mixture to dryness under vacuum, the residue was
puri!ed by silica gel column chromatography to give 13b.2 (0.45 g,
86% yield, m.p.:120e122 !C). 1H NMR (DMSO!d6): d 1.16 (t,
J " 7.2 Hz, 3H, NHCH2CH3), 2.37 (s, 3H, SCH 3), 3.38 (qd, J " 7.2 Hz/
5.3 Hz, 2H, NHCH2CH3), 4.76 (s, 2H, NH2), 6.94 (t, J" 4.8 Hz,1H, NH).
13C NMR (DMSO!d6): d 13.5, 14.3, 35.7, 119.8, 137.2, 152.4, 155.7.
4.17. 6-Chloro-2-(ethylthio)-N4-methylpyrimidine-4,5-diamine
(13b.3)
4,6-Dichloro-2-(ethylthio)pyrimidin-5-amine (12b.2) (0.5 g,
2.2 mmol) was dissolved in methanol (2 mL) and supplemented
with a solution of methylamine 33% w/w in methanol (0.80 mL,
6.6 mmol). The reaction mixture was introduced in a sealed vessel
and heated at 100 !C for 1 h. After concentration of the reaction
mixture to dryness under vacuum, the residuewas puri!ed by silica
gel column chromatography to give 13b.3 (0.43 g, 87% yield, m.p.:
112e114 !C). 1H NMR (DMSO!d6): d 1.27 (t, J" 7.2 Hz, 3H, SCH2CH3),
2.87 (d, J " 3.8 Hz, 3H, NHCH3), 2.97 (q, J " 7.2 Hz, 2H, SCH2CH3),
4.70 (s, 2H, NH2), 7.00 (s, 1H, NH). 13C NMR (DMSO!d6): d 14.9, 24.5,
27.8, 120.1, 137.2, 153.3, 155.4.
4.18. 6-Chloro-N4-ethyl-2-(ethylthio)pyrimidine-4,5-diamine
(13b.4)
4,6-Dichloro-2-(ethylthio)pyrimidin-5-amine (12b.2) (0.5 g,
2.2 mmol) was dissolved in a solution of ethylamine 2.0 M in
methanol (3.3 mL, 6.6 mmol). The reaction mixture was introduced
in a sealed vessel and heated at 100 !C for 1 h. After concentration
of the reaction mixture to dryness under vacuum, the residue was
puri!ed by silica gel column chromatography to give 13b.4 (0.47 g,
91% yield, m.p.: 93e95 !C). 1H NMR (DMSO!d6): d 1.16 (t, J " 7.2 Hz,
3H, NHCH2CH3), 1.27 (t, J " 7.2 Hz, 3H, SCH2CH3), 2.96 (q, J " 7.2 Hz,
2H, SCH2CH3), 3.38 (p, J " 6.1 Hz, 2H, NHCH2CH3), 4.74 (s, 2H, NH2),




4,6-Dichloro-2-(propylthio)pyrimidin-5-amine 12b.3 (0.5 g,
2.1 mmol) was dissolved in methanol (2 mL) and supplemented
with a solution of methylamine 33% w/w in methanol (0.76 mL,
6.3 mmol). The reaction mixture was introduced in a sealed vessel
and heated at 100 !C for 1 h. After concentration of the reaction
mixture to dryness under vacuum, the residuewas puri!ed by silica
gel column chromatography to give 13b.5 (0.47 g, 96% yield, m.p.:
119e121 !C). 1H NMR (DMSO!d6): d 0.95 (t, J " 7.4 Hz, 3H,
SCH2CH2CH3), 1.64 (h, J " 7.3 Hz, 2H, SCH2CH2CH3), 2.87 (d,
J " 4.5 Hz, 3H, NHCH3), 2.96 (t, J " 7.2 Hz, 2H, SCH2CH2CH3), 4.71 (s,
2H, NH2), 7.01 (q, J " 4.4 Hz, 1H, NHCH3). 13C NMR (DMSO!d6):
d 13.3, 22.6, 27.8, 32.1, 120.0, 137.1, 153.2, 155.4.
4.20. 6-Chloro-N4-ethyl-2-(propylthio)pyrimidine-4,5-diamine
(13b.6)
4,6-Dichloro-2-(propylthio)pyrimidin-5-amine 12b.3 (0.5 g,
2.1 mmol) was dissolved in a solution of ethylamine 2.0 M in
methanol (3.2 mL, 6.4 mmol). The reaction mixture was introduced
in a sealed vessel and heated at 100 !C for 1 h. After concentration
of the reaction mixture to dryness under vacuum, the residue was
puri!ed by silica gel column chromatography to give 13b.6 (0.4 g,
77% yield, m.p.: 96e98 !C). 1H NMR (DMSO!d6): d 0.95 (t, J " 7.4 Hz,
3H, SCH2CH2CH3), 1.16 (t, J " 7.2 Hz, 3H, NHCH2CH3), 1.63 (h,
J " 7.3 Hz, 2H, SCH2CH2CH3), 2.94 (t, J " 7.2 Hz, 2H, SCH2CH2CH3),
3.37 (m, 2H, NHCH2CH3), 4.75 (s, 2H, NH2), 6.95 (t, J " 4.8 Hz, 1H,




4,6-Dichloro-2-(propylthio)pyrimidin-5-amine 12b.3 (0.5 g,
2.1 mmol) was dissolved in methanol (2 mL) and supplemented
with cyclopentylamine (536.0 mg, 6.3 mmol). The reaction mixture
was introduced in a sealed vessel and heated at 100 !C for 2 h. After
concentration of the reaction mixture to dryness under vacuum,
the residue was puri!ed by silica gel column chromatography to
give 13b.7 (0.57 g, 95% yield, oil). 1H NMR (DMSO!d6): d 0.95 (t,
J " 7.4 Hz, 3H, SCH2CH2CH3), 1.49 (m, 2H, 20-Ha/50-Ha), 1.55 (m, 2H,
30-Ha/40-Ha), 1.64 (m, 2H, SCH2CH2CH3), 1.70 (m, 2H, 30-Hb/40-Hb),
1.96 (m, 2H, 20-Hb/50-Hb), 2.94 (t, J " 7.2 Hz, 2H, SCH2CH2CH3), 4.25
(h, J" 6.7 Hz,1H,10-H), 4.83 (s, 2H, NH2), 6.76 (d, J" 6.3 Hz,1H, NH).
13C NMR (DMSO!d6): d 13.3, 22.9, 23.5, 32.1, 32.2, 52.7, 119.9, 137.2,
152.0, 155.0.




The mixture of 4,6-dichloro-2-(propylthio)pyrimidin-5-amine
12b.3 (1.0 g, 4.2 mmol), (3aR,4S,6R,6aS)-6-amino-2,2-
dimethyltetrahydrocyclopenta[d][1,3]dioxol-4-ol (0.93 g,
5.4 mmol) and triethylamine (0.6 mL, 4.2 mmol) in acetonitrile
(10 mL) was introduced in a sealed vessel and heated overnight at
110 !C. After evaporation of the solvent, the residue was puri!ed by
column chromatography on silica gel using 100% ethyl acetate to
give 13b.8 as a brown oil (1.40 g, 89% yield, oil). 1H NMR (CDCl3):
d 1.03 (t, J " 7.4 Hz, 3H, SCH2CH2CH3), 1.26 (s, 3H, CH3), 1.43 (s, 3H,
CH3), 1.76 (m, 2H, SCH2CH2CH3), 1.83 (d, J " 14.5 Hz, 1H, 50-Ha), 2.14
(s, 1H, OH), 2.36 (m,1H, 50-Hb), 3.01 (ddd, J" 13.4 Hz/8.3 Hz/6.4 Hz,
1H, SCHa), 3.09 (s, 2H, NH2), 3.13 (ddd, J" 13.5 Hz/8.3 Hz/6.4 Hz,1H,
SCHb), 4.38 (s, 1H, 40-H), 4.51 (dd, J " 5.4 Hz/1.7 Hz, 1H, 3a0-H), 4.57
(dd, J " 5.4 Hz/1.2 Hz, 1H, 6a0-H), 4.62 (t, J " 7.4 Hz, 1H, 60-H), 5.93
(d, J" 8.4 Hz,1H, NH). 13C NMR (CDCl3): d 13.5, 23.2, 23.8, 26.2, 33.2,




The mixture of 4,6-dichloro-2-(propylthio)pyrimidin-5-amine
12b.3 (1.0 g, 4.2 mmol), 2-(((3aR,4S,6R,6aS)-6-amino-2,2-
dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)
ethanol (1.17 g, 5.4 mmol) and triethylamine (0.6 mL, 4.2 mmol) in
acetonitrile (10 mL) was introduced in a sealed vessel and heated
overnight at 110 !C. After evaporation of the solvent, the residue
was puri!ed by column chromatography on silica gel using 100%
ethyl acetate to give 13b.9 (1.36 g, 77% yield, m.p.: 112e114 !C). 1H
NMR (CDCl3) d 1.03 (t, J" 7.4 Hz, 3H, SCH2CH2CH3), 1.26 (s, 3H, CH3),
1.43 (s, 3H, CH3), 1.75 (m, 2H, SCH2CH2CH3), 1.92 (d, J " 14.5 Hz, 1H,
50-Ha), 2.28 (ddd, J " 14.5 Hz/5.9 Hz/4.4 Hz, 1H, 50-Hb), 2.59 (bs, 1H,
OH), 2.99 (ddd, J " 13.4 Hz/8.2 Hz/6.4 Hz, 1H, SCHa), 3.14 (ddd,
J " 13.5 Hz/8.2 Hz/6.4 Hz, 1H, SCHb), 3.38 (bs, 2H, NH2), 3.60 (ddd,
J " 9.9 Hz/6.1 Hz/2.6 Hz, 1H, OCHa), 3.70 (ddd, J " 9.9 Hz/5.8 Hz/
2.5 Hz, 1H, OCHb), 3.79 (m, 2H, OCH2CH2OH), 3.97 (d, J " 4.1 Hz, 1H,
40-H), 4.53 (dd, J " 5.4 Hz/1.2 Hz, 1H, 3a0-H), 4.59 (m, 1H, 60-H), 4.61
(dd, J " 5.5 Hz/1.8 Hz, 1H, 6a0-H), 6.17 (d, J " 8.4 Hz, 1H, NH). 13C
NMR (CDCl3) d 13.5, 23.2, 23.8, 26.2, 32.5, 33.2, 56.8, 61.9, 70.4, 82.8,




To a solution of 13c.1 (1.0 g, 3.1 mmol) in acetic acid (10 mL)
cooled on an ice bath was added NaNO2 (275 mg, 4.0 mmol). The
mixture was allowed to reach room temperature within 1 h and
water (40mL) was then added. The resulting mixturewas extracted
with ethyl acetate (3 $ 50 mL) and the combined organic layers
were dried over MgSO4 and evaporated to give 14c.1 as an oily
residue (0.95 g, 92% yield). 1H NMR (DMSO!d6) d 1.23 (s, 3H, CH3),
1.48 (s, 3H, CH3), 2.59 (m, 2H, 50-H), 4.17 (td, J" 6.1 Hz/2.6 Hz,1H, 40-
H), 4.61 (dd, J" 6.8 Hz/2.6 Hz,1H, 3a0-H), 5.20 (bs, 1H, OH), 5.25 (dd,
J " 7.3 Hz/3.6 Hz, 1H, 60-H), 5.42 (dd, J " 6.8 Hz/3.6 Hz, 1H, 6a0-H),
9.11 (s, 1H, 2-H). 13C NMR (DMSO) d 24.7, 26.9, 38.1, 62.1, 74.2, 82.3,




To a solution of 13a.1 (1.0 g, 3.0 mmol) in acetic acid (10 mL)
cooled on an ice bath was added NaNO2 (275 mg, 4.0 mmol). The
mixture was allowed to reach room temperature within 1 h and
water (40 mL) was then added. The precipitate was !ltered and
washed with water to give 14a.1 as a white solid (0.61 g, 59% yield,
decomposition at 280 !C). 1H NMR (CDCl3) d 1.34 (s, 3H, CH3), 1.54
(s, 3H, CH3), 2.41 (d, J " 15.2 Hz, 1H, 50-Ha), 2.90 (ddd, J " 15.1 Hz/
8.0 Hz/5.7 Hz,1H, 50-Hb), 3.23 (d, J" 5.2 Hz,1H, OH), 4.46 (bs,1H, 40-
H), 4.81 (d, J " 5.7 Hz, 1H, 3a0-H), 5.17 (d, J " 5.7 Hz, 1H, 6a0-H), 5.39
(d, J" 7.2 Hz,1H, 60-H). 13C NMR (CDCl3) d 24.2, 26.6, 37.2, 64.7, 76.6,




To a solution of 13a.2 (1.0 g, 2.6 mmol) in acetic acid (10 mL)
cooled on an ice bath was added NaNO2 (240 mg, 3.5 mmol). The
mixture was allowed to reach room temperature within 1 h and
water (40mL) was then added. The resulting mixture was extracted
with ethyl acetate (3 $ 50 mL) and the combined organic layers
were dried over MgSO4 and evaporated to give 14a.2 as an oily
residue (0.92 g, 89% yield). 1H NMR (DMSO!d6) d 1.27 (s, 3H, CH3),
1.48 (s, 3H, CH3), 2.44 (m,1H, 50-Ha), 2.90 (dt, J" 13.1 Hz/6.0 Hz,1H,
50-Hb), 3.39e3.51 (m, 4H, OCH2CH2OH), 4.01 (m, 1H, 40-H), 4.32 (bs,
12H, OCH2CH2OH/H2O), 4.69 (dd, J " 7.2 Hz/2.9 Hz, 1H, 3a0-H), 5.01
(m, 1H, 60-H), 5.17 (dd, J " 7.1 Hz/4.7 Hz, 1H, 6a0-H). 13C NMR




To a solution of 13b.1 (1.0 g, 4.9 mmol) in acetic acid (10 mL)
cooled on an ice bath was added NaNO2 (450 mg, 6.5 mmol). The
mixture was allowed to reach room temperature within 1 h and
water (40 mL) was then added. The precipitate was !ltered and
washed with water to give 14b.1 as a beige solid (1.0 g, 95% yield).
1H NMR (DMSO!d6) d 2.66 (s, 3H, SCH 3), 4.23 (s, 3H, NCH3). 13C
NMR (DMSO!d6) d 14.2, 33.3, 131.2, 150.8, 151.7, 170.3.
4.28. 7-Chloro-3-ethyl-5-(methylthio)-3H-[1,2,3]triazolo[4,5-d]
pyrimidine (14b.2)
To a solution of 13b.2 (1.0 g, 4.6 mmol) in acetic acid (10 mL)
cooled on an ice bath was added NaNO2 (415 mg, 6.0 mmol). The
mixture was allowed to reach room temperature within 1 h and
water (40 mL) was then added. The precipitate was !ltered and
washed with water to give 14b.2 as a beige solid (0.92 g, 87% yield).
1H NMR (DMSO!d6) d 1.56 (t, J " 7.3 Hz, 3H, NCH2CH3), 2.65 (s, 3H,
SCH 3), 4.66 (q, J" 7.3 Hz, 2H, NCH2CH3). 13C NMR (DMSO!d6) d 14.2,
42.4, 131.4, 150.4, 151.7, 170.2.
4.29. 7-Chloro-5-(ethylthio)-3-methyl-3H-[1,2,3]triazolo[4,5-d]
pyrimidine (14b.3)
To a solution of 13b.3 (1.0 g, 4.6 mmol) in acetic acid (10 mL)
cooled on an ice bath was added NaNO2 (415 mg, 6.0 mmol). The
mixture was allowed to reach room temperature within 1 h and
water (40 mL) was then added. The precipitate was !ltered and
washed with water to give 14b.3 as a beige solid (0.70 g, 87% yield).
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1H NMR (DMSO!d6) d 1.39 (t, J " 7.3 Hz, 3H, SCH2CH3), 3.25 (q,
J " 7.3 Hz, 2H, SCH2CH3), 4.22 (s, 3H, NCH3). 13C NMR (DMSO!d6)
d 14.0, 25.5, 33.3, 131.3, 150.8, 151.8, 169.7.
4.30. 7-Chloro-3-ethyl-5-(ethylthio)-3H-[1,2,3]triazolo[4,5-d]
pyrimidine (14b.4)
To a solution of 13b.4 (1.0 g, 4.3 mmol) in acetic acid (10 mL)
cooled on an ice bath was added NaNO2 (395 mg, 5.7 mmol). The
mixture was allowed to reach room temperature within 1 h and
water (40 mL) was then added. The precipitate was !ltered and
washed with water to give 14b.4 as a beige solid (0.88 g, 87% yield).
1H NMR (DMSO!d6) d 1.39 (t, J " 7.3 Hz, 3H, SCH2CH3), 1.56 (t,
J " 7.3 Hz, 3H, NCH2CH3), 3.24 (q, J " 7.3 Hz, 2H, SCH2CH3), 4.66 (q,
J" 7.3 Hz, 2H, NCH2CH3). 13C NMR (DMSO!d6) d 13.9,14.2, 25.5, 42.5,
131.5, 150.4, 151.8, 169.6.
4.31. 7-Chloro-3-methyl-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]
pyrimidine (14b.5)
To a solution of 13b.5 (1.0 g, 4.3 mmol) in acetic acid (10 mL)
cooled on an ice bath was added NaNO2 (395 mg, 5.7 mmol). The
mixture was allowed to reach room temperature within 1 h and
water (40 mL) was then added. The precipitate was !ltered and
washed with water to give 14b.5 as an orange solid (0.87 g, 84%
yield). 1H NMR (DMSO!d6) d 1.03 (t, J " 7.1 Hz, 3H, SCH2CH2CH3),
1.76 (h, J " 7.0 Hz, 2H, SCH2CH2CH3), 3.23 (t, J " 7.1 Hz, 2H,
SCH2CH2CH3), 4.22 (s, 3H, NCH3). 13C NMR (DMSO!d6) d 13.2, 21.7,
32.8, 33.2, 131.3, 150.8, 151.7, 169.8.
4.32. 7-Chloro-3-ethyl-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]
pyrimidine (14b.6)
To a solution of 13b.6 (1.0 g, 4.0 mmol) in acetic acid (10 mL)
cooled on an ice bath was added NaNO2 (375 mg, 5.4 mmol). The
mixture was allowed to reach room temperature within 1 h and
water (40 mL) was then added. The precipitate was !ltered and
washed with water to give 14b.6 as an orange solid (0.90 g, 86%
yield). 1H NMR (DMSO!d6) d 1.02 (t, J " 7.4 Hz, 3H, SCH2CH2CH3),
1.56 (t, J " 7.3 Hz, 3H, NCH2CH3), 1.76 (h, J " 7.4 Hz, 2H,
SCH2CH2CH3), 3.24 (t, J " 7.2 Hz, 2H, SCH2CH2CH3), 4.66 (q,
J" 7.3 Hz, 2H, NCH2CH3). 13C NMR (DMSO!d6) d 13.3, 14.2, 21.7, 32.9,
42.5, 131.5, 150.3, 151.8, 169.7.
4.33. 7-Chloro-3-cyclopentyl-5-(propylthio)-3H-[1,2,3]triazolo[4,5-
d]pyrimidine (14b.7)
To a solution of 13b.7 (1.0 g, 3.5 mmol) in acetic acid (10 mL)
cooled on an ice bath was added NaNO2 (320 mg, 4.6 mmol). The
mixture was allowed to reach room temperature within 1 h and
water (40 mL) was then added. The precipitate was !ltered and
washed with water to give 14b.7 as an orange solid (0.70 g, 67%
yield). 1H NMR (DMSO!d6) d 1.03 (t, J " 7.3 Hz, 3H, SCH2CH2CH3),
1.76 (m, 4H, 30-Ha/40-Ha/SCH2CH2CH3), 1.93 (m, 2H, 30-Hb/40-Hb),
2.24 (m, 4H, 20-H2/50-H2), 3.21 (t, J " 7.1 Hz, 2H, SCH2CH2CH3), 5.35
(p, J " 7.1 Hz, 1H, 10-H). 13C NMR (DMSO!d6) d 13.2, 21.8, 24.3, 31.8,




To a solution of 13b.8 (1.0 g, 2.7 mmol) in acetic acid (10 mL)
cooled on an ice bath was added NaNO2 (250 mg, 3.6 mmol). The
mixture was allowed to reach room temperature within 1 h and
water (40mL) was then added. The resulting mixturewas extracted
with ethyl acetate (3 $ 50 mL) and the combined organic layers
were dried over MgSO4 and evaporated to give 14b.8 as an oily
residue (0.88 g, 85% yield). 1H NMR (CDCl3) d 1.10 (t, J " 7.4 Hz, 3H,
SCH2CH2CH3), 1.33 (s, 3H, CH3), 1.54 (s, 3H, CH3), 1.83 (h, J " 7.3 Hz,
2H, SCH2CH2CH3), 2.38 (d, J " 15.3 Hz, 1H, 50-Ha), 2.90 (m, 1H, 50-
Hb), 3.24 (td, J" 7.1 Hz/1.7 Hz, 2H, SCH2CH2CH3), 3.76 (d, J " 8.8 Hz,
1H, OH), 4.44 (m, 1H, 40-H), 4.80 (d, J " 5.6 Hz, 1H, 3a0-H), 5.04 (d,
J " 5.7 Hz, 1H, 6a0-H), 5.34 (d, J " 7.7 Hz, 1H, 60-H). 13C NMR (CDCl3)





To a solution of 13b.9 (1.0 g, 2.4 mmol) in acetic acid (10 mL)
cooled on an ice bath was added NaNO2 (225 mg, 3.2 mmol). The
mixture was allowed to reach room temperature within 1 h and
water (40mL) was then added. The resulting mixturewas extracted
with ethyl acetate (3 $ 50 mL) and the combined organic layers
were dried over MgSO4 and evaporated to give 14b.9 as an oily
residue (0.96 g, 94% yield). 1H NMR (CDCl3) d 1.09 (t, J " 7.4 Hz, 3H,
SCH2CH2CH3), 1.37 (s, 3H, CH3), 1.55 (s, 3H, CH3), 1.83 (h, J " 7.4 Hz,
2H, SCH2CH2CH3), 2.14 (t, J " 6.0 Hz, 1H, OH), 2.54 (m, 1H, 50-Ha),
2.70 (m, 1H, 50-Hb), 3.21 (t, J " 7.2 Hz, 2H, SCH2CH2CH3), 3.49e3.65
(m, 4H, OCH2CH2OH), 4.05 (m, 1H, 40-H), 4.88 (d, J " 6.3 Hz, 1H, 3a0-
H), 5.21 (td, J " 7.4 Hz/6.4 Hz/2.5 Hz, 1H, 60-H), 5.53 (dd, J " 6.3 Hz/
2.1 Hz,1H, 6a0-H). 13C NMR (CDCl3) d 13.6, 22.3, 24.5, 26.8, 33.9, 35.9,




The mixture of 14c.1 (0.5 g, 1.6 mmol), (1R,2S)-2-(3,4-
di"uorophenyl)cyclopropanamine (0.41 g, 2.4 mmol) and triethyl-
amine (0.29 mL, 2.05 mmol) in acetonitrile (10 mL) was left to react
at room temperature for 2 h. After evaporation of the solvent, the
residue was puri!ed by column chromatography on silica gel using
hexane/ethyl acetate gradient to give 15c.1 as a white solid (0.67 g,
94% yield). 1H NMR (DMSO!d6) d 1.26 (s, 3H, CH3), 1.37 (q, J" 6.0 Hz,
0.8H, 30-Ha major), 1.42 (m, 0.2H, 30-Ha minor), 1.47 (m, 3.2H, CH3/
30-Hb minor), 1.54 (dt, J " 9.9 Hz/5.3 Hz, 0.8H, 30-Hb major), 2.18
(ddd, J" 9.4 Hz/6.3 Hz/3.3 Hz, 0.8H, 20-Hmajor), 2.26 (m, 0.2H, 20-H
minor), 2.45e2.60 (m, 2H, 5000-H), 3.28 (dd, J " 7.7 Hz/3.6 Hz, 0.8H,
10-Hmajor), 3.78 (m, 0.2H, 10-Hminor), 4.14 (m,1H, 4000-H), 4.57 (dd,
J " 7.1 Hz/2.8 Hz, 1H, 3a’’’-H), 5.08 (td, J " 7.9 Hz/4.4 Hz, 1H, 6000-H),
5.22 (m, 0.2H, 6a’’’-H minor), 5.29 (m, 1.8H, 6a’’’-H major/OH), 7.03
(m, 0.2H, 200-Hminor), 7.09 (m, 0.8H, 600-Hmajor), 7.27e7.37 (m, 2H,
200-H/500-H), 8.32 (s, 0.2H, 2-Hminor), 8.42 (s, 0.8H, 2-Hminor), 9.01
(d, J " 3.7 Hz, 0.2H, NHminor), 9.34 (d, J " 4.0 Hz, 0.8H, NHmajor).
13C NMR (DMSO!d6) d 15.2, 23.7, 24.7, 26.9, 33.9, 37.9, 62.1, 74.3,
82.2, 86.0, 112.0, 114.8, 117.1, 122.9, 124.6, 139.2, 146.8, 148.1, 148.4,




The solution of 14a.1 (0.5 g, 1.45 mmol) in THF (10 mL) was
saturated with ammonia gas in a sealed vessel and left to react at
room temperature for 1 h. After evaporation of the solvent, the
residue was puri!ed by column chromatography on silica gel using
hexane/ethyl acetate gradient to give 15a.1 as a white solid (0.45 g,
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95% yield). 1H NMR (DMSO!d6) d 1.26 (s, 3H, CH3), 1.47 (s, 3H, CH3),
2.42 (m, 1H, 50-Ha), 2.55 (m, 1H, 50-Hb), 4.13 (m, 1H, 40-H), 4.56 (dd,
J " 7.0 Hz/3.0 Hz, 1H, 3a0-H), 4.98 (ddd, J " 8.6 Hz/7.0 Hz/4.2 Hz, 1H,
60-H), 5.25 (m, 2H, OH/6a0-H), 8.64 (bs, 1H, NHa), 8.96 (bs, 1H, NHb).
13C NMR (DMSO!d6) d 24.7, 26.8, 37.8, 61.9, 74.2, 82.1, 85.9, 112.0,





The mixture of 14a.1 (0.5 g, 1.45 mmol), (1R,2S)-2-(3,4-
di"uorophenyl)cyclopropanamine (0.37 g, 2.2 mmol) and triethyl-
amine (0.26 mL, 1.86 mmol) in acetonitrile (10 mL) was left to react
at room temperature for 30 min. After evaporation of the solvent,
the residue was puri!ed by column chromatography on silica gel
using hexane/ethyl acetate gradient to give 15a.2 as a white solid
(0.59 g, 85% yield, decomposition at 85 !C). 1H NMR (DMSO!d6)
d 1.25 (s, 0.9H, CH3 minor), 1.26 (s, 2.1H, CH3 major), 1.41e1.50 (m,
5H, CH3/30-H2), 2.23 (ddd, J " 9.7 Hz/6.6 Hz/3.3 Hz, 0.7H, 20-H
major), 2.29 (ddd, J " 9.5 Hz/6.5 Hz/3.2 Hz, 0.3H, 20-H minor),
2.35e2.44 (m, 1H, 5000-Ha), 2.56 (m, 1H, 5000-Hb), 3.13 (dt, J " 7.7 Hz/
3.9 Hz, 0., 10-H major), 3.79 (m, 0.3H, 10-H minor), 4.14 (m, 1H, 4000-
H), 4.54 (dd, J " 7.0 Hz/2.8 Hz, 0.3H, 3a’’’-H minor), 4.57 (dd,
J " 7.0 Hz/2.8 Hz, 0.7H, 3a’’’-H major), 4.97 (td, J " 8.3 Hz/4.3 Hz,
0.3H, 6000-H minor), 5.00 (td, J " 7.9 Hz/4.1 Hz, 0.7H, 6000-H major),
5.21 (dd, J " 6.9 Hz/4.2 Hz, 0.3H, 6a’’’-H minor), 5.23 (d, J " 4.6 Hz,
1H, OH), 5.27 (dd, J " 6.9 Hz/4.1 Hz, 0.7H, 6a’’’-H major), 7.03 (bs,
0.3H, 600-H minor), 7.14 (bs, 0.7H, 600-H major), 7.25 (m, 0.3H, 200-H
minor), 7.31e7.37 (m,1H, 500-H), 7.40 (m, 0.7H, 200-Hmajor), 9.55 (bs,
0.3H, NH minor), 9.81 (bs, 0.7H, NH major). 13C NMR (DMSO!d6)
d 14.5, 23.7, 24.7, 26.9, 33.6, 37.9, 62.2, 74.3, 82.2, 86.0, 112.0, 117.1,






The mixture of 14a.2 (0.5 g, 1.28 mmol), (1R,2S)-2-(3,4-
di"uorophenyl)cyclopropanamine (0.33 g, 1.9 mmol) and triethyl-
amine (0.23 mL, 1.64 mmol) in acetonitrile (10 mL) was left to react
at room temperature for 30 min. After evaporation of the solvent,
the residue was puri!ed by column chromatography on silica gel
using hexane/ethyl acetate gradient to give 15a.3 as a yellowish
solid (0.62 g, 92% yield). 1H NMR (DMSO!d6) d 1.26 (s, 0.9H, CH3
minor), 1.27 (s, 2.1H, CH3 major), 1.42e1.50 (m, 5H, CH3/30-H2), 2.24
(ddd, J " 9.7 Hz/6.5 Hz/3.4 Hz, 0.7H, 20-H major), 2.29 (ddd,
J " 9.6 Hz/6.5 Hz/3.2 Hz, 0.3H, 20-Hminor), 2.5 (m, 1H, 5000-Ha), 2.66
(m, 1H, 5000-Hb), 3.14 (dt, J " 7.8 Hz/3.9 Hz, 0.7H, 10-H major),
3.38e3.51 (m, 4H, OCH2CH2OH), 3.77 (m, 0.3H, 10-H minor), 4.00
(m, 1H, 4000-H), 4.56 (m, 1H, OH), 4.67 (dd, J " 7.3 Hz/3.1 Hz, 0.3H,
3a’’’-H minor), 4.70 (dd, J " 7.3 Hz/3.1 Hz, 0.7H, 3a’’’-H major), 5.01
(ddd, J " 10.1 Hz/6.8 Hz/5.0 Hz, 0.3H, 6000-H minor), 5.04 (ddd,
J " 9.7 Hz/6.8 Hz/4.7 Hz, 0.7H, 6000-H major), 5.17 (dd, J " 7.3 Hz/
4.8 Hz, 0.3H, 6a’’’-Hminor), 5.22 (dd, J " 7.3 Hz/4.6 Hz, 0.7H, 6a’’’-H
major), 7.03 (d, J " 8.3 Hz, 0.3H, 600-H minor), 7.14 (d, J " 8.3 Hz,
0.7H, 600-H major), 7.25 (ddd, J " 12.0 Hz/7.8 Hz/2.0 Hz, 0.3H, 200-H
minor), 7.31e7.37 (m,1H, 500-H), 7.40 (ddd, J" 12.0 Hz/7.8 Hz/2.0 Hz,
0.7H, 200-H major), 9.56 (d, J " 4.9 Hz, 0.3H, NH minor), 9.83 (d,
J " 3.4 Hz, 0.7H, NH major). 13C NMR (DMSO!d6) d 14.5, 23.7, 24.7,
26.8, 33.6, 35.5, 60.0, 61.7, 70.7, 81.9, 83.7, 112.5, 114.9, 115.6, 117.0,




The mixture of 14b.1 (0.5 g, 2.3 mmol), (1R,2S)-2-(3,4-
di"uorophenyl)cyclopropanamine (0.59 g, 3.45 mmol) and trie-
thylamine (0.42 mL, 2.95 mmol) in acetonitrile (10 mL) was left to
react at room temperature for 2 h. After evaporation of the solvent,
the residue was puri!ed by column chromatography on silica gel
using hexane/ethyl acetate gradient to give 7a as a white solid
(0.69 g, 86% yield, m.p.: 213e216 !C). 1H NMR (DMSO!d6) d 1.37 (q,
J " 6.2 Hz, 0.8H, 30-Ha major), 1.44 (m, 0.4H, 30-H minor), 1.52 (m,
0.8H, 30-Hb major), 2.14 (ddd, J " 9.5 Hz/6.3 Hz/3.3 Hz, 0.8H, 20-H
major), 2.23 (m, 0.2H, 20-Hminor), 2.34 (s, 2.4H, SCH 3 major), 2.52
(s, 0.6H, SCH 3minor), 3.15 (m, 0.8H,10-Hmajor), 3.76 (m, 0.2H,10-H
minor), 4.04 (s, 0.6H, NCH3 minor), 4.06 (s, 2.4H, NCH3 major), 7.02
(m, 0.2H, 600-Hminor), 7.09 (m, 0.8H, 600-Hmajor), 7.22e7.36 (m, 2H,
200-H/500-H), 8.96 (d, J " 4.6 Hz, 0.2H, NH minor), 9.34 (d, J " 3.6 Hz,
0.8H, NH major). 13C NMR (DMSO!d6) d 13.6, 15.0, 24.0, 33.0, 33.9,
115.0, 117.0, 122.6, 122.9, 139.2, 146.8, 148.4, 148.7, 148.9, 150.3,
153.9, 169.8. Anal. (C15H14F2N6S) theoretical: C, 51.71; H, 4.05; N,
24.12; S, 9.20. Found: C, 51.86; H, 4.27; N, 24.33, S, 9.13.
4.41. N-((1R,2S)-2-(3,4-di"uorophenyl)cyclopropyl)-3-ethyl-5-
(methylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine (7b)
The mixture of 14b.2 (0.5 g, 2.2 mmol), (1R,2S)-2-(3,4-
di"uorophenyl)cyclopropanamine (0.56 g, 3.3 mmol) and triethyl-
amine (0.4 mL, 2.8 mmol) in acetonitrile (10 mL) was left to react at
room temperature for 2 h. After evaporation of the solvent, the
residue was puri!ed by column chromatography on silica gel using
hexane/ethyl acetate gradient to give 7b as a white solid (0.58 g,
73% yield, m.p.: 164e165 !C). 1H NMR (DMSO!d6) d 1.37 (q,
J " 6.2 Hz, 1H, 30-Ha), 1.49 (m, 4H, 30-Hb/NCH2CH3), 2.13 (ddd,
J " 9.4 Hz/6.3 Hz/3.3 Hz, 0.8H, 20-H major), 2.25 (m, 0.2H, 20-H
minor), 2.33 (s, 2.4H, SCH 3 major), 2.52 (s, 0.6H, SCH 3 minor), 3.14
(m, 0.8H, 10-Hmajor), 3.78 (m, 0.2H, 10-Hminor), 4.49 (q, J " 7.3 Hz,
2H, NCH2CH3), 7.02 (m, 0.2H, 600-H minor), 7.09 (m, 0.8H, 600-H
major), 7.22e7.36 (m, 2H, 200-H/500-H), 8.95 (d, J " 4.6 Hz, 0.2H, NH
minor), 9.35 (d, J " 3.7 Hz, 0.8H, NH major). 13C NMR (DMSO!d6)
d 13.6, 14.5, 15.0, 24.0, 33.9, 41.3, 115.0, 117.0, 122.8, 123.0, 139.2,
146.8, 148.3, 148.7, 148.8, 150.3, 153.9, 169.8. Anal. (C16H16F2N6S)
theoretical: C, 53.03; H, 4.45; N, 23.19; S, 8.85. Found: C, 52.94; H,
4.75; N, 23.30, S, 8.64.
4.42. N-((1R,2S)-2-(3,4-di"uorophenyl)cyclopropyl)-5-(ethylthio)-
3-methyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine (7c)
The mixture of 14b.3 (0.5 g, 2.2 mmol), (1R,2S)-2-(3,4-
di"uorophenyl)cyclopropanamine (0.56 g, 3.3 mmol) and triethyl-
amine (0.4 mL, 2.8 mmol) in acetonitrile (10 mL) was left to react at
room temperature for 2 h. After evaporation of the solvent, the
residue was puri!ed by column chromatography on silica gel using
hexane/ethyl acetate gradient to give 7c as awhite solid (0.45 g, 58%
yield, m.p.: 210e212 !C). 1H NMR (DMSO!d6) d 1.09 (t, J " 7.3 Hz,
2.5 Hz, SCH2CH3major),1.35 (m,1.4H, 30-Hamajor/SCH2CH3minor),
1.44 (m, 0.4H, 30-H minor), 1.56 (m, 0.8H, 30-Hb major), 2.13 (ddd,
J " 9.5 Hz/6.3 Hz/3.3 Hz, 0.8H, 20-H major), 2.24 (m, 0.2H, 20-H
minor), 2.89 (m, 1.6H, SCH2CH3 major), 3.12 (m, 0.4H, SCH2CH3
minor), 3.17 (m, 0.8H, 10-H major), 3.75 (m, 0.2H, 10-H minor), 4.03
(s, 0.6H, NCH3 minor), 4.05 (s, 2.4H, NCH3 major), 7.01 (m, 0.2H, 600-
Hminor), 7.07 (m, 0.8H, 600-Hmajor), 7.21e7.36 (m, 2H, 200-H/500-H),
8.96 (d, J " 4.7 Hz, 0.2H, NH minor), 9.36 (d, J " 3.8 Hz, 0.8H, NH
major). 13C NMR (DMSO!d6) d 14.6, 15.2, 24.0, 24.8, 32.4, 34.1, 114.7,
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117.0, 122.7, 122.8, 139.4, 147.0, 148.4, 148.7, 149.4, 150.0, 153.9,
169.3. Anal. (C16H16F2N6S) theoretical: C, 53.03; H, 4.45; N, 23.19; S,
8.85. Found: C, 53.05; H, 4.65; N, 23.27, S, 8.41.
4.43. N-((1R,2S)-2-(3,4-di"uorophenyl)cyclopropyl)-5-(ethylthio)-
3-ethyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine (7d)
The mixture of 14b.4 (0.5 g, 2.05 mmol), (1R,2S)-2-(3,4-
di"uorophenyl)cyclopropanamine (0.52 g, 3.1 mmol) and triethyl-
amine (0.37 mL, 2.6 mmol) in acetonitrile (10 mL) was left to react
at room temperature for 2 h. After evaporation of the solvent, the
residue was puri!ed by column chromatography on silica gel using
hexane/ethyl acetate gradient to give 7d as a white solid (0.69 g,
90% yield, m.p.: 145e146.5 !C). 1H NMR (DMSO!d6) d 1.09 (t,
J " 7.3 Hz, 2.4H, SCH2CH3 major), 1.35 (m, 1.4H, 30-Ha major/
SCH2CH3 minor), 1.44 (m, 0.2H, 30-Ha minor), 1.47 (t, J " 7.3 Hz,
3.2H, NCH2CH3/30-Hbminor), 1.56 (m, 0.8H, 30-Hbmajor), 2.12 (ddd,
J " 9.5 Hz/6.3 Hz/3.3 Hz, 0.8H, 20-H major), 2.24 (m, 0.2H, 20-H
minor), 2.88 (m, 1.6H, SCH2CH3 major), 3.11 (m, 0.4H, SCH2CH3
minor), 3.16 (m, 0.8H, 10-H major), 3.77 (m, 0.2H, 10-H minor), 4.48
(q, J " 7.3 Hz, 2H, NCH2CH3), 7.02 (m, 0.2H, 600-H minor), 7.07 (m,
0.8H, 600-Hmajor), 7.23e7.36 (m, 2H, 200-H/500-H), 8.96 (d, J" 3.9 Hz,
0.2H, NH minor), 9.37 (s, 0.8H, NH major). 13C NMR (DMSO!d6)
d 14.5,14.6,15.2, 24.0, 24.8, 34.1, 41.3,114.8,117.0,122.8,122.9,139.4,
147.0, 148.4, 148.7, 148.9, 150.0, 154.0, 169.2. Anal. (C17H18F2N6S)
theoretical: C, 54.24; H, 4.82; N, 22.33; S, 8.52. Found: C, 54.25; H,
5.13; N, 22.48, S, 8.43.
4.44. N-((1R,2S)-2-(3,4-di"uorophenyl)cyclopropyl)-3-methyl-5-
(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine (7e)
The mixture of 14b.5 (0.5 g, 2.05 mmol), (1R,2S)-2-(3,4-
di"uorophenyl)cyclopropanamine (0.52 g, 3.1 mmol) and triethyl-
amine (0.37 mL, 2.6 mmol) in acetonitrile (10 mL) was heated at
50 !C for 2 h. After evaporation of the solvent, the residue was
puri!ed by column chromatography on silica gel using hexane/
ethyl acetate gradient to give 7e as a white solid (0.53 g, 69% yield,
m.p.: 185e187 !C). 1H NMR (DMSO!d6) d 0.80 (t, J " 7.4 Hz, 2.4H,
SCH2CH2CH3 major), 1.00 (t, J " 7.3 Hz, 0.6H, SCH2CH2CH3 minor),
1.37 (m, 0.8H, 30-Ha major), 1.43 (m, 0.2H, 30-Ha minor), 1.49 (m,
1.8H, 30-Hb minor/SCH2CH2CH3 major), 1.56 (m, 0.8H, 30-Hbmajor),
1.70 (h, J " 7.3 Hz, 0.4H, SCH2CH2CH3 minor), 2.13 (ddd, J " 9.5 Hz/
6.3 Hz/3.2 Hz, 0.8H, 20-Hmajor), 2.23 (m, 0.2H, 20-Hminor), 2.88 (m,
1.6H, SCH2CH2CH3 major), 3.11 (t, J " 7.2 Hz, 0.4H, SCH2CH2CH3
minor), 3.17 (m, 0.8H, 10-H major), 3.75 (m, 0.2H, 10-H minor), 4.03
(s, 0.6H, NCH3 minor), 4.05 (s, 2.4H, NCH3 major), 7.02 (m, 0.2H, 600-
Hminor), 7.07 (m, 0.8H, 600-Hmajor), 7.22e7.37 (m, 2H, 200-H/500-H),
8.96 (s, 0.2H, NH minor), 9.36 (s, 0.8H, NH major). 13C NMR
(DMSO!d6) d 12.9, 15.1, 22.2, 24.0, 32.3, 32.4, 34.2, 117.0, 122.6, 122.7,
139.4, 146.7, 148.4, 148.7, 149.3, 150.3, 153.8, 169.3. Anal.
(C17H18F2N6S) theoretical: C, 54.24; H, 4.82; N, 22.33; S, 8.52.
Found: C, 54.25; H, 4.87; N, 22.38, S, 7.89.
4.45. N-((1R,2S)-2-(3,4-di"uorophenyl)cyclopropyl)-3-ethyl-5-
(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine (7f)
The mixture of 14b.6 (0.5 g, 1.95 mmol), (1R,2S)-2-(3,4-
di"uorophenyl)cyclopropanamine (0.50 g, 2.95 mmol) and trie-
thylamine (0.35mL, 2.5mmol) in acetonitrile (10mL) was heated at
50 !C for 2 h. After evaporation of the solvent, the residue was
puri!ed by column chromatography on silica gel using hexane/
ethyl acetate gradient to give 7f as a white solid (0.45 g, 59% yield,
m.p.: 136e138 !C). 1H NMR (DMSO!d6) d 0.81 (t, J " 7.4 Hz, 2.4H,
SCH2CH2CH3 major), 0.99 (t, J " 7.3 Hz, 0.6H, SCH2CH2CH3 minor),
1.37 (m, 0.8H, 30-Ha major), 1.41 (m, 0.2H, 30-Ha minor), 1.49 (m,
4.8H, 30-Hb minor/SCH2CH2CH3 major/NCH2CH3), 1.56 (m, 0.8H, 30-
Hb major), 1.70 (h, J " 7.1 Hz, 0.4H, SCH2CH2CH3 minor), 2.13 (ddd,
J " 9.5 Hz/6.3 Hz/3.3 Hz, 0.8H, 20-H major), 2.25 (ddd, J " 9.1 Hz/
6.2 Hz/3.2 Hz, 0.2H, 20-Hminor), 2.88 (m,1.6H, SCH2CH2CH3 major),
3.10 (t, J " 7.0 Hz, 0.4H, SCH2CH2CH3 minor), 3.16 (m, 0.8H, 10-H
major), 3.76 (m, 0.2H,10-Hminor), 4.48 (q, J" 7.3 Hz, 2H, NCH2CH3),
7.02 (m, 0.2H, 200-H minor), 7.07 (m, 0.8H, 600-H major), 7.23e7.36
(m, 2H, 200-H/500-H), 8.94 (d, J " 4.0 Hz, 0.2H, NH minor), 9.35 (s,
0.8H, NH major). 13C NMR (DMSO!d6) d 13.0, 14.5, 15.0, 22.3, 24.0,
32.3, 34.1, 41.3, 114.8, 117.0, 122.8, 122.9, 139.4, 147.0, 148.4, 148.7,
148.8, 150.1, 153.9, 169.6. Anal. (C18H20F2N6S) theoretical: C, 55.37;




The mixture of 14b.7 (0.5 g, 1.67 mmol), (1R,2S)-2-(3,4-
di"uorophenyl)cyclopropanamine (0.42 g, 2.5 mmol) and triethyl-
amine (0.3 mL, 2.1 mmol) in acetonitrile (10 mL) was heated at
50 !C for 2 h. After evaporation of the solvent, the residue was
puri!ed by column chromatography on silica gel using hexane/
ethyl acetate gradient to give 7g as a white solid (0.53 g, 74% yield,
m.p.: 113.5e115 !C). 1H NMR (DMSO!d6) d 0.82 (t, J " 7.2 Hz, 2.4H,
SCH2CH2CH3 major), 0.99 (t, J " 7.3 Hz, 0.6H, SCH2CH2CH3 minor),
1.38 (m, 1H, 30-Ha), 1.44e1.55 (m, 2.6H, 30-Hb/SCH2CH2CH3 major),
1.72 (m, 2.4H, SCH2CH2CH3 minor/3000-Ha/4000-Ha), 1.90 (m, 2H, 3000-
Hb/4000-Hb), 2.12e2.19 (m, 5H, 20-H/2000-H2/5000-H2), 2.89 (m, 1.6H,
SCH2CH2CH3 major), 3.10 (m, 0.4H, SCH2CH2CH3 minor), 3.14 (m,
0.8H, 10-Hmajor), 3.78 (m, 0.2H, 10-Hminor), 5.15 (p, J " 7.2 Hz, 1H,
1000-H), 7.02 (m, 0.2H, 600-H minor), 7.08 (m, 0.8H, 600-H major),
7.22e7.37 (m, 2H, 200-H/500-H), 8.94 (bs, 0.2H, NH minor), 9.33 (bs,
0.8H, NH major). 13C NMR (DMSO!d6) d 13.0, 15.0, 22.3, 24.0, 24.2,
31.8, 32.3, 34.0, 58.3, 114.8, 117.0, 122.8, 123.1, 139.3, 146.8, 148.4,
148.6, 148.7, 150.3, 153.9, 169.0. Anal. (C21H24F2N6S) theoretical: C,





The solution of 14b.8 (0.5 g, 1.3 mmol) in THF (10 mL) was
saturated with ammonia gas in a sealed vessel and left to react at
room temperature for 1 h. After evaporation of the solvent, the
residue was puri!ed by column chromatography on silica gel using
hexane/ethyl acetate gradient to give 16a as a white solid (0.38 g,
79% yield). 1H NMR (DMSO!d6) d 1.00 (t, J " 7.4 Hz, 3H,
SCH2CH2CH3), 1.26 (s, 3H, CH3), 1.47 (s, 3H, CH3), 1.71 (h, J " 7.3 Hz,
2H, SCH2CH2CH3), 2.47 (m, 1H, 50-Ha), 2.56 (m, 1H, 50-Hb), 3.08 (m,
2H, SCH2CH2CH3), 4.13 (m, 1H, 40-H), 4.54 (dd, J " 7.0 Hz/3.0 Hz, 1H,
3a0-H), 4.99 (ddd, J " 9.1 Hz/7.0 Hz/4.4 Hz, 1H, 60-H), 5.25 (dd,
J" 7.0 Hz/4.4 Hz,1H, 6a0-H), 5.28 (d, J" 4.7 Hz,1H, OH), 8.09 (bs,1H,
NHa), 8.43 (bs, 1H, NHb). 13C NMR (DMSO!d6) d 13.4, 22.6, 24.7, 26.9,





The mixture of 14b.8 (0.5 g, 1.3 mmol), (1R,2S)-2-(3,4-
di"uorophenyl)cyclopropanamine (0.33 g, 1.95 mmol) and trie-
thylamine (0.23 mL, 1.6 mmol) in acetonitrile (10 mL) was heated at
80 !C for 2 h. After evaporation of the solvent, the residue was
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puri!ed by column chromatography on silica gel using hexane/
ethyl acetate gradient to give 16b as a white solid (0.62 g, 92%
yield). 1H NMR (DMSO!d6) d 0.84 (t, J " 7.3 Hz, 2.4H, SCH2CH2CH3
major), 1.00 (t, J " 7.3 Hz, 0.6H, SCH2CH2CH3 minor), 1.26 (s, 3H,
CH3), 1.38 (m, 1H, 30-Ha), 1.47 (s, 3H, CH3), 1.53 (m, 2.6H, 30-Hb/
SCH2CH2CH3 major), 1.71 (h, J " 7.1 Hz, 0.4H, SCH2CH2CH3 minor),
2.13 (m, 0.8H, 20-H major), 2.25 (m, 0.2H, 20-H minor), 2.45 (m, 1H,
5000-Ha), 2.54 (m,1H, 5000-Hb), 2.88 (dt, J" 13.6 Hz/7.2 Hz, 0.8H, SCHa
major), 2.94 (dt, J " 14.2 Hz/7.2 Hz, 0.8H, SCHb major), 3.09 (m,
0.4H, SCH 2 minor), 3.15 (m, 0.8H, 10-H major), 3.75 (m, 0.2H, 10-H
minor), 4.13 (m, 1H, 4000-H), 4.55 (m, 1H, 3a’’’-H), 4.98 (m, 1H, 6000-H),
5.21 (m, 0.2H, 6a’’’-H minor), 5.25 (m, 1.8H, 6a’’’-H major/OH), 7.02
(bs, 0.2H, 600-H minor), 7.07 (bs, 0.8H, 600-H major), 7.22e7.36 (m,
2H, 200-H/500-H), 8.99 (d, J " 4.7 Hz, 0.2H, NH minor), 9.38 (d,
J " 4.0 Hz, 0.8H, NH major). 13C NMR (DMSO!d6) d 13.1, 15.0, 22.4,
24.1, 24.8, 27.0, 32.4, 34.1, 37.9, 61.9, 74.3, 82.2, 86.2, 112.0, 114.9,





The solution of 14b.9 (0.5 g, 1.16 mmol) in THF (10 mL) was
saturated with ammonia gas in a sealed vessel and left to react at
room temperature for 1 h. After evaporation of the solvent, the
residue was puri!ed by column chromatography on silica gel using
hexane/ethyl acetate gradient to give 16c as a white solid (0.36 g,
75% yield). 1H NMR (DMSO!d6) d 1.00 (t, J " 7.3 Hz, 3H,
SCH2CH2CH3), 1.27 (s, 3H, CH3), 1.49 (s, 3H, CH3), 1.71 (h, J " 7.2 Hz,
2H, SCH2CH2CH3), 2.56 (dt, J " 13.0 Hz/9.7 Hz, 1H, 50-Ha), 2.67 (dt,
J" 13.0 Hz/6.6 Hz, 1H, 50-Hb), 3.08 (m, 2H, SCH2CH2CH3), 3.40e3.51
(m, 4H, OCH2CH2OH), 4.01 (m, 1H, 40-H), 4.56 (t, J " 5.2 Hz, 1H, OH),
4.67 (dd, J " 7.3 Hz/3.1 Hz, 1H, 3a0-H), 5.02 (m, 1H, 60-H), 5.22 (dd,
J " 7.2 Hz/4.9 Hz, 1H, 6a0-H), 8.10 (bs, 1H, NHa), 8.44 (bs, 1H, NHb).
13C NMR (DMSO!d6) d 13.4, 22.6, 24.8, 26.9, 32.2, 35.3, 60.0, 61.4,




The mixture of 14b.9 (0.5 g, 1.16 mmol), cyclopropylamine
(0.12 g, 1.74 mmol) and triethylamine (0.21 mL, 1.45 mmol) in
acetonitrile (10mL) was heated at 80 !C for 2 h. After evaporation of
the solvent, the residuewas puri!ed by column chromatography on
silica gel using hexane/ethyl acetate gradient to give 16d as a white
solid (0.48 g, 91% yield). 1H NMR (DMSO!d6) d 0.68 (m, 2H, 20-Ha/30-
Ha), 0.76 (m, 1.4H, 20-Hb major/30-Hb major), 0.87 (m, 0.6H, 20-Hb
minor/30-Hbminor),1.00 (t, J" 7.3 Hz, 3H, SCH2CH2CH3), 1.26 (s, 3H,
CH3), 1.49 (s, 3H, CH3), 1.73 (m, 2H, SCH2CH2CH3), 2.54 (m, 1H, 500-
Ha), 2.65 (m, 1H, 500-Hb), 3.05 (m, 0.7H, 10-H major), 3.10 (m, 2H,
SCH2CH2CH3), 3.39e3.51 (m, 4.3H, 10-H minor/OCH2CH2OH), 4.00
(m, 1H, 400-H), 4.57 (bs, 1H, OH), 4.67 (dd, J " 7.3 Hz/3.2 Hz, 1H, 6a’’-
H), 5.01 (m, 1H, 600-H), 5.20 (m, 1H, 3a’’-H), 8.83 (d, J " 4.1 Hz, 0.3H,
NHminor), 9.11 (d, J " 4.3 Hz, 0.7H, NHmajor). 13C NMR (DMSO!d6)
d 5.9, 7.5, 13.6, 22.7, 23.7, 24.7, 26.9, 32.5, 35.4, 60.0, 61.3, 70.7, 81.8,





The mixture of 14b.9 (0.5 g, 1.16 mmol), (1R,2S)-2-
phenylcyclopropanamine hydrochloride (0.3 g, 1.74 mmol) and
triethylamine (0.21 mL, 1.45 mmol) in acetonitrile (10 mL) was
heated at 80 !C for 2 h. After evaporation of the solvent, the residue
was puri!ed by column chromatography on silica gel using hexane/
ethyl acetate gradient to give 16e as awhite solid (0.54 g, 88% yield).
1H NMR (DMSO!d6) d 0.83 (t, J " 7.3 Hz, 2.4H, SCH2CH2CH3 major),
1.00 (m, 0.6H, SCH2CH2CH3 minor), 1.27 (s, 3H, CH3), 1.33 (m, 1H, 30-
Ha), 1.40 (m, 0.2H, 30-Hb minor), 1.50 (m, 5.4H, CH3/30-Hb major/
SCH2CH2CH3 major), 1.71 (h, J " 7.1 Hz, 0.4H, SCH2CH2CH3 minor),
2.14 (m, 0.8H, 20-H major), 2.26 (m, 0.2H, 20-H minor), 2.51 (m, 1H,
5000-Ha), 2.66 (m, 1H, 5000-Hb), 2.91 (m, 1.6H, SCH2CH2CH3 major),
3.09 (m, 0.4H, SCH2CH2CH3 minor), 3.20 (m, 0.8H, 10-H major),
3.39e3.50 (m, 4H, OCH2CH2OH), 3.82 (m, 0.2H, 10-H minor), 4.00
(m, 1H, 4000-H), 4.57 (t, J " 4.6 Hz, 1H, OH), 4.67 (m, z, 1H, 6a’’’-H),
5.01 (m, 1H, 6000-H), 5,20 (m, 1H, 3a’’’-H), 7.19 (m, 3H, 200-H/400-H/600-
H), 7.29 (t, J " 7.5 Hz, 2H, 300-H/500-H), 8.99 (d, J " 4.4 Hz, 0.2H, NH
minor), 9.37 (d, J " 3.6 Hz, 0.8H, NH major). 13C NMR (DMSO!d6)
d 13.1, 15.0, 22.4, 24.4, 24.8, 26.9, 32.5, 33.8, 35.4, 60.1, 61.4, 70.7,





The mixture of 14b.9 (0.5 g, 1.16 mmol), 2-(3,4-di"uorophenyl)
ethanamine (0.27 g, 1.74 mmol) and triethylamine (0.21 mL,
1.45 mmol) in acetonitrile (10 mL) was heated at 80 !C for 2 h. After
evaporation of the solvent, the residue was puri!ed by column
chromatography on silica gel using hexane/ethyl acetate gradient to
give 16f as a white solid (0.53 g, 83% yield). 1H NMR (DMSO!d6)
d 0.99 (t, J " 7.1 Hz, 3H, SCH2CH2CH3), 1.26 (s, 3H, CH3), 1.48 (s, 3H,
CH3), 1.70 (h, J" 7.3 Hz, 2H, SCH2CH2CH3), 2.50 (m,1H, 5000-Ha), 2.65
(m, 1H, 5000-Hb), 2.95 (m, 2H, 20-H2), 3.07 (m, 2H, SCH2CH2CH3),
3.40e3.51 (m, 4H, OCH2CH2OH), 3.73 (q, J " 6.8 Hz, 1.6H, 10-H2
major), 4.00 (m, 1H, 4000-H), 4.10 (q, J " 6.9 Hz, 0.4H, 10-H2 minor),
4.58 (t, J " 5.0 Hz, 1H, OH), 4.67 (dd, J " 7.3 Hz/3.2 Hz, 1H, 3a’’’-H),
5.01 (m, 1H, 6000-H), 5.19 (m, 0.2H, 6a’’’-H), 7.07 (m, 0.8H, 600-H ma-
jor), 7.15 (m, 0.2H, 600-H minor), 7.29e7.41 (m, 2H, 200-H/500-H), 8.74
(t, J " 6.3 Hz, 0.2H, NH minor), 9.09 (d, J " 5.6 Hz, 0.8H, NH major).
13C NMR (DMSO!d6) d 13.3, 22.7, 24.7, 26.9, 32.4, 33.5, 35.4, 41.1,
60.0, 61.3, 70.7, 81.8, 83.7, 112.5, 117.0, 117.6, 123.0, 125.4, 137.1, 147.0,





The mixture of 14b.9 (0.5 g, 1.16 mmol), (1R,2S)-2-(3,4-
di"uorophenyl)cyclopropanamine (0.3 g, 1.74 mmol) and triethyl-
amine (0.21 mL, 1.45 mmol) in acetonitrile (10 mL) was heated at
80 !C for 2 h. After evaporation of the solvent, the residue was
puri!ed by column chromatography on silica gel using hexane/
ethyl acetate gradient to give 16g as awhite solid (0.56 g, 86% yield).
1H NMR (DMSO!d6) d 0.84 (t, J " 7.4 Hz, 2.4H, SCH2CH2CH3 major),
1.00 (t, J " 7.3 Hz, 0.6H, SCH2CH2CH3 minor), 1.26 (s, 3H, CH3), 1.38
(m, 1H, 30-Ha), 1.48 (s, 3H, CH3), 1.53 (m, 2.6H, 30-Hb/SCH2CH2CH3
major), 1.71 (h, J " 7.2 Hz, 0.4H, SCH2CH2CH3 minor), 2.13 (m, 0.8H,
20-H major), 2.24 (m, 0.2H, 20-H minor), 2.50 (m, 1H, 5000-Ha), 2.65
(m, 1H, 5000-Hb), 2.89 (m, 0.8H, SCHa major), 2.93 (m, 0.8H, SCHb
major), 3.08 (m, 0.4H, SCH 2 minor), 3.15 (m, 0.8H, 10-H major),
3.39e3.51 (m, 4H, OCH2CH2OH), 3.75 (m, 0.2H,10-Hminor), 4.01 (m,
1H, 4000-H), 4.56 (t, J " 5.2 Hz, 1H, OH), 4.64 (dd, J " 7.3 Hz/3.2 Hz,
0.2H, 3a’’’-Hminor), 4.68 (dd, J" 7.3 Hz/3.2 Hz, 0.8H, 3a’’’-Hmajor),
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5.01 (m,1H, 6000-H), 5.17 (m, 0.2H, 6a’’’-Hminor), 5.21 (m, 0.8H, 6a’’’-
H major), 7.02 (bs, 0.2H, 600-H minor), 7.08 (bs, 0.8H, 600-H major),
7.22e7.37 (m, 2H, 200-H/500-H), 9.00 (d, J " 4.7 Hz, 0.2H, NH minor),
9.39 (d, J " 3.9 Hz, 0.8H, NHmajor). 13C NMR (DMSO!d6) d 13.1, 15.0,
22.4, 24.0, 24.8, 26.9, 32.4, 34.0, 35.5, 59.8, 60.0, 61.4, 70.7, 81.9, 83.7,





The mixture of 15a.1 (0.3 g, 0.92 mmol), 1-mercaptopropan-2-ol
(0.12 mL, 1.38 mmol) and K2CO3 (0.19 g, 1.38 mmol) in acetonitrile
(3 mL) was heated in a sealed vessel at 100 !C for 1 h. After evap-
oration of the solvent, the residue was taken up with water (25 mL)
and extracted with dichloromethane (3 $ 25 mL). The combined
organic layers were dried over MgSO4, evaporated and puri!ed by
column chromatography on silica gel using hexane/ethyl acetate
gradient to give 16h as an oily residue (0.27 g, 77% yield). 1H NMR
(DMSO!d6) d 1.18 (d, J" 6.2 Hz, 3H, CHOHCH3), 1.26 (s, 3H, CH3), 1.47
(s, 3H, CH3), 2.46 (m, 1H, 50-Ha), 2.57 (m, 1H, 50-Hb), 3.10 (ddd,
J" 13.4 Hz/6.6 Hz/4.3 Hz, 1H, SCHa), 3.22 (dt, J" 13.3 Hz/5.4 Hz,1H,
SCHb), 3.89 (ddt, J " 11.6 Hz/8.6 Hz/4.1 Hz, 1H, CHOHCH3), 4.13 (m,
1H, 40-H), 4.55 (m,1H, 3a0-H), 4.86 (dd, J" 4.9 Hz/1.4 Hz,1H, 40-OH),
4.98 (ddd, J " 9.0 Hz/7.0 Hz/4.3 Hz, 1H, 60-H), 5.25 (m, 1H, 6a0-H),
5.27 (d, J " 4.8 Hz, 1H, CHOHCH3), 8.10 (bs, 1H, NHa), 8.43 (bs, 1H,
NHb). 13C NMR (DMSO!d6) d 22.7, 24.8, 26.9, 37.8, 47.8, 61.8, 65.4,




Themixture of 15a.1 (0.3 g, 0.92 mmol), 3-mercapto-1-propanol
(0.12 mL, 1.38 mmol) and K2CO3 (0.19 g, 1.38 mmol) in acetonitrile
(3 mL) was heated in a sealed vessel at 100 !C for 1 h. After evap-
oration of the solvent, the residue was taken up with water (25 mL)
and extracted with dichloromethane (3 $ 25 mL). The combined
organic layers were dried over MgSO4, evaporated and puri!ed by
column chromatography on silica gel using hexane/ethyl acetate
gradient to give 16i as an oily residue (0.25 g, 71% yield). 1H NMR
(DMSO!d6) d 1.26 (s, 3H, CH3), 1.47 (s, 3H, CH3), 1.84 (m, 2H,
SCH2CH2CH2OH), 2.48 (m, 1H, 50-Ha), 2.55 (m, 1H, 50-Hb), 3.14 (t,
J" 7.2 Hz, 2H, SCH 2), 3.52 (t, J" 6.2 Hz,1H, CH2OH), 4.13 (m,1H, 40-
H), 4.55 (m, 2H, 3a0-H/CH2OH), 4.98 (ddd, J " 9.1 Hz/7.0 Hz/4.4 Hz,
1H, 60-H), 5.26 (m, 2H, 6a0-H/40-OH), 8.09 (bs, 1H, NHa), 8.43 (bs, 1H,
NHb). 13C NMR (DMSO!d6) d 24.7, 26.9, 27.2, 32.3, 37.7, 59.5, 61.9,





Themixture of 15a.2 (0.3 g, 0.63 mmol), 3-mercapto-1-propanol
(0.08 mL, 0.96 mmol) and K2CO3 (0.13 g, 0.96 mmol) in acetonitrile
(3 mL) was heated in a sealed vessel at 100 !C for 1 h. After evap-
oration of the solvent, the residue was taken up with water (25 mL)
and extracted with dichloromethane (3 $ 25 mL). The combined
organic layers were dried over MgSO4, evaporated and puri!ed by
column chromatography on silica gel using hexane/ethyl acetate
gradient to give 16j as a white solid (0.24 g, 72% yield). 1H NMR
(DMSO!d6) d 1.26 (s, 3H, CH3), 1.38 (q, J " 6.3 Hz, 1H, 30-Ha), 1.47 (s,
3H, CH3), 1.52 (dt, J " 9.9 Hz/5.4 Hz, 1H, 30-Hb), 1.70 (p, J " 6.6 Hz,
1.6H, SCH2CH2CH2OH major), 1.84 (p, J " 6.7 Hz, 0.4H,
SCH2CH2CH2OH minor), 2.14 (m, 0.8H, 20-H major), 2.25 (m, 0.2H,
20-H minor), 2.44 (m, 1H, 5000-Ha), 2.54 (m, 1H, 5000-Hb), 2.97 (dt,
J " 13.8 Hz/7.1 Hz, 0.8H, SCHa major), 3.03 (dt, J " 13.9 Hz/7.0 Hz,
0.8H, SCHb major), 3.16 (m, 1.2H, SCH 2 minor/10-H major), 3.40 (q,
J " 6.0 Hz, 1.6H, CH2OH major), 3.53 (q, J " 5.6 Hz, 0.4H, CH2OH
minor), 3.76 (m, 0.2H, 10-H minor), 4.13 (m, 1H, 4000-H), 4.49 (t,
J" 5.1 Hz, 0.8H, CH2OHmajor), 4.55 (m,1.2H, CH2OHminor/3a’’’-H),
4.98 (m,1H, 6000-H), 5.22 (m, 0.2H, 6a’’’-Hminor), 5.26 (m,1.8H, 6a’’’-
H major/4000-OH), 7.02 (bs, 0.2H, 600-H minor), 7.08 (bs, 0.8H, 600-H
major), 7.22e7.36 (m, 2H, 200-H/500-H), 8.99 (d, J " 4.6 Hz, 0.2H, NH
minor), 9.37 (d, J " 3.9 Hz, 0.8H, NH major). 13C NMR (DMSO!d6)
d 15.0, 23.9, 24.7, 26.9, 27.3, 32.2, 33.9, 37.8, 59.3, 61.9, 74.3, 82.1,






Themixture of 15a.2 (0.3 g, 0.63 mmol), (R)-1-mercaptopropan-
2-ol (0.08 mL, 0.96 mmol) and K2CO3 (0.13 g, 0.96 mmol) in
acetonitrile (3 mL) was heated in a sealed vessel at 100 !C for 1 h.
After evaporation of the solvent, the residue was taken up with
water (25 mL) and extracted with dichloromethane (3 $ 25 mL).
The combined organic layers were dried over MgSO4, evaporated
and puri!ed by column chromatography on silica gel using hexane/
ethyl acetate gradient to give 16k as a white solid (0.25 g, 75%
yield). 1H NMR (DMSO!d6) d 1.01 (d, J " 6.1 Hz, 2.4H, CHOHCH3
major), 1.18 (d, J " 6.0 Hz, 0.6H, CHOHCH3 minor), 1.26 (s, 3H, CH3),
1.38 (m, 1H, 30-Ha), 1.47 (s, 3H, CH3), 1.53 (m, 1H, 30-Hb), 2.13 (m,
0.8H, 20-H major), 2.24 (m, 0.2H, 20-H minor), 2.43 (m, 1H, 5000-Ha),
2.55 (m,1H, 5000-Hb), 2.88 (dd, J" 13.4 Hz/7.0 Hz, 0.8H, SCHamajor),
3.10e3.18 (m, 1.8H, SCHa minor/SCHb major/10-H major), 3.23 (dd,
J" 13.3 Hz/5.2 Hz, 0.2H, SCHbminor), 3.78 (m,1H, CHOHCH3major/
10-H minor), 3.90 (m, 0.2H, CHOHCH3 minor), 4.14 (bs, 1H, 4000-H),
4.56 (m,1H, 3a’’’-H), 4.79 (d, J" 4.8 Hz, 0.8H, CHOHCH3 major), 4.87
(d, J " 4.2 Hz, 0.2H, CHOHCH3 minor), 4.99 (m, 1H, 6000-H), 5.22 (m,
0.2H, 6a’’’-H minor), 5.26 (m, 1.8H, 6a’’’-H major/4000-OH), 7.02 (bs,
0.2H, 600-Hminor), 7.09 (bs, 0.8H, 600-Hmajor), 7.22e7.36 (m, 2H, 200-
H/500-H), 9.00 (d, J " 4.8 Hz, 0.2H, NH minor), 9.37 (d, J " 4.0 Hz,
0.8H, NH major). 13C NMR (DMSO!d6) d 15.0, 22.5, 24.0, 24.7, 26.9,
33.9, 37.8, 39.3, 61.8, 65.1, 74.3, 82.1, 86.1, 111.9, 114.9, 117.1, 123.0,





The mixture of 15a.2 (0.3 g, 0.63 mmol), (S)-1-mercaptopropan-
2-ol (0.08 mL, 0.96 mmol) and K2CO3 (0.13 g, 0.96 mmol) in
acetonitrile (3 mL) was heated in a sealed vessel at 100 !C for 1 h.
After evaporation of the solvent, the residue was taken up with
water (25 mL) and extracted with dichloromethane (3 $ 25 mL).
The combined organic layers were dried over MgSO4, evaporated
and puri!ed by column chromatography on silica gel using hexane/
ethyl acetate gradient to give 16l as awhite solid (0.28 g, 84% yield).
1H NMR (DMSO!d6) d 1.01 (d, J" 6.1 Hz, 2.4H, CHOHCH3 major), 1.18
(d, J " 6.0 Hz, 0.6H, CHOHCH3 minor), 1.25 (s, 3H, CH3), 1.37 (m,
0.8H, 30-Ha major), 1.40 (m, 0.2H, 30-Ha minor), 1.47 (s, 3.2H, 30-Hb
minor/CH3), 1.51 (m, 0.8H, 30-Hb major), 2.14 (m, 0.8H, 20-H major),
2.24 (m, 0.2H, 20-H minor), 2.43 (m, 1H, 4000-Ha), 2.55 (m, 1H, 4000-
Hb), 3.06 (m, 1.6H, SCH 2 major), 3.12 (m, 0.2H, SCHa minor), 3.17
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(m, 0.8H, 10-H major), 3.23 (dd, J " 13.5 Hz/5.1 Hz, 0.2H, SCHb mi-
nor), 3.77 (m, 1H, CHOHCH3 major/10-H minor), 3.88 (m, 0.2H,
CHOHCH3 minor), 4.13 (bs, 1H, 4000-H), 4.56 (m, 1H, 3a’’’-H), 4.79 (d,
J " 4.8 Hz, 0.8H, CHOHCH3 major), 4.86 (d, J " 4.8 Hz, 0.2H,
CHOHCH3 minor), 4.99 (m, 1H, 6000-H), 5.20 (m, 0.2H, 6a’’’-Hminor),
5.25 (m,1.8H, 6a’’’-Hmajor/4000-OH), 7.02 (m, 0.2H, 600-Hminor), 7.08
(m, 0.8H, 600-H major), 7.23e7.35 (m, 2H, 200-H/500-H), 8.99 (d,
J " 4.2 Hz, 0.2H, NHminor), 9.36 (d, J " 3.1 Hz, 0.8H, NHmajor). 13C
NMR (DMSO!d6) d 15.0, 22.6, 23.9, 24.7, 26.9, 33.8, 37.8, 39.2, 61.8,
65.2, 74.3, 82.1, 86.1, 111.9, 115.0, 117.0, 123.0, 123.1, 139.1, 147.2,





The mixture of 15a.3 (0.3 g, 0.57 mmol), 1-mercaptopropan-2-ol
(0.07 mL, 0.87 mmol) and K2CO3 (0.12 g, 0.87 mmol) in acetonitrile
(3 mL) was heated in a sealed vessel at 100 !C for 3 h. After evap-
oration of the solvent, the residue was taken up with water (25 mL)
and extracted with dichloromethane (3 $ 25 mL). The combined
organic layers were dried over MgSO4, evaporated and puri!ed by
column chromatography on silica gel using hexane/ethyl acetate
gradient to give 16m as a white solid (0.25 g, 74% yield). 1H NMR
(DMSO!d6) d 1.01 (d, J" 6.1 Hz,1.2H, CHOHCH3major R or S), 1.05 (d,
J " 6.1 Hz, 1.2H, CHOHCH3 major R or S), 1.18 (m, 0.6H, CHOHCH3
minor), 1.27 (s, 3H, CH3), 1.38 (m, 1H, 30-Ha), 1.49 (s, 3H, CH3), 1.52
(m, 1H, 30-Hb), 2.14 (m, 1H, 20-H major), 2.25 (m, 1H, 20-H minor),
2.50 (m, 1H, 5000-Ha), 2.66 (m, 1H, 5000-Hb), 2.88 (dd, J " 13.5 Hz/
7.0 Hz, 0.4H, SCHa major R or S), 3.02 (dd, J " 13.4 Hz/6.8 Hz, 0.4H,
SCHa major R or S), 3.08e3.17 (m, 2H, SCHa minor/SCHb/10-H ma-
jor), 3.40e3.50 (m, 4H, OCH2CH2OH), 3.76 (m,1H, CHOHmajor/10-H
minor), 3.88 (m, 0.2H, CHOH minor), 4.00 (m, 1H, 4000-H), 4.56 (t,
J " 4.5 Hz, 1H, OCH2CH2OH), 4.67 (m, 1H, 3a’’’-H), 4.79 (m, 0.8H,
CHOHmajor), 4.85 (m, 0.2H, CHOHminor), 5.02 (m, 1H, 6000-H), 5.17
(m, 0.2H, 6a’’’-Hminor), 5.22 (m, 0.8H, 6a’’’-Hmajor), 7.02 (bs, 0.2H,
600-H minor), 7.09 (bs, 1H, 600-H major), 7.22e7.36 (m, 2H, 200-H/500-
H), 9.00 (d, J " 4.5 Hz, 0.2H, NH minor), 9.37 (m, 0.8H, NH major).
13C NMR (DMSO!d6) d 15.0, 22.5, 22.6, 23.9, 24.8, 26.9, 33.8, 35.5,
39.2, 60.0, 61.4, 65.1, 70.7, 81.9, 82.0, 83.7, 112.5, 115.0, 117.1, 123.0,





Themixture of 15a.3 (0.3 g, 0.57 mmol), 3-mercapto-1-propanol
(0.07 mL, 0.87 mmol) and K2CO3 (0.12 g, 0.87 mmol) in acetonitrile
(3 mL) was heated in a sealed vessel at 100 !C for 1 h. After evap-
oration of the solvent, the residue was taken up with water (25 mL)
and extracted with dichloromethane (3 $ 25 mL). The combined
organic layers were dried over MgSO4, evaporated and puri!ed by
column chromatography on silica gel using hexane/ethyl acetate
gradient to give 16n as a white solid (0.22 g, 65% yield). 1H NMR
(DMSO!d6) d 1.27 (s, 3H, CH3), 1.37 (q, J " 6.2 Hz, 1H, 30-Ha), 1.49 (s,
3H, CH3), 1.52 (dt, J " 10.4 Hz/5.5 Hz, 1H, 30-Hb), 1.70 (p, J " 6.7 Hz,
1.6H, SCH2CH2CH2OH major), 1.84 (p, J " 6.7 Hz, 0.4H,
SCH2CH2CH2OH minor), 2.15 (ddd, J " 9.5 Hz/6.4 Hz/3.3 Hz, 0.8H,
20-H major), 2.24 (m, 0.2H, 20-H minor), 2.51 (m, 1H, 5000-Ha), 2.66
(m,1H, 5000-Hb), 3.00 (m,1.6H, SCH2CH2CH2OHmajor), 3.16 (m,1.2H,
SCH2CH2CH2OH minor/10-H major), 3.38e3.54 (m, 6H,
SCH2CH2CH2OH/OCH2CH2OH), 3.74 (m, 0.2H, 10-H minor), 4.00 (m,
1H, 4000-H), 4.50 (t, J " 5.1 Hz, 0.8H, SCH2CH2CH2OH major), 4.55 (t,
J " 5.2 Hz, 0.2H, SCH2CH2CH2OH minor), 4.58 (t, J " 5.1 Hz, 1H,
OCH2CH2OH), 4.67 (m, 1H, 3a’’’-H), 5.02 (m, 1H, 6000-H), 5.18 (m,
0.2H, 6a’’’-Hminor), 5.22 (dd, J" 7.2 Hz/4.9 Hz, 0.8H, 6a’’’-Hmajor),
7.02 (m, 0.2H, 600-H minor), 7.08 (m, 0.8H, 600-H major), 7.22e7.36
(m, 2H, 200-H/500-H), 8.99 (d, J " 4.6 Hz, 0.2H, NH minor), 9.37 (d,
J " 3.8 Hz, 0.8H, NH major). 13C NMR (DMSO!d6) d 15.1, 23.9, 24.8,






To a solution of 15c.1 (0.15 g, 0.34 mmol) in MeOH (3 mL), was
added HCl 12 N (1 mL). After 30 min at room temperature, meth-
anol was evaporated under reduced pressure and the resulting
residue was suspended in water (20 mL), neutralized with NaOH
10% and extracted with dichloromethane (3 $ 20 mL). The com-
bined organic layers were dried over MgSO4, concentrated under
reduced pressure and puri!ed by column chromatography on silica
gel using ethyl acetate 100% to give 7u as a white solid (0.12 g, 88%
yield, m.p.: 148e152 !C). 1H NMR (DMSO!d6) d 1.37 (m, 0.8H, 30-Ha
major), 1.41 (m, 0.2H, 30-Haminor),1.49 (m, 0.2H, 30-Hbminor), 1.54
(m, 0.8H, 30-Hb major), 1.94 (m, 1H, 5000-Ha), 2.19 (m, 0.8H, 20-H
major), 2.26 (m, 0.2H, 20-H minor), 2.63 (m, 1H, 5000-Hb), 3.29 (m,
0.8H, 10-H major), 3.80 (m, 1H, 3000-H), 3.82 (m, 0.2H, 10-H minor),
3.94 (m, 1H, 1000-H), 4.67 (m, 1H, 2000-H), 4.93 (d, J " 3.6 Hz, 1H, 3000-
OH), 5.06 (m, 2H, 2000-OH, 4000-H), 5.16 (d, J" 5.2 Hz, 1H, 1000-OH), 7.05
(m, 0.2H, 600-Hminor), 7.09 (m, 0.8H, 600-Hmajor), 7.27e7.36 (m, 2H,
200-H/500-H), 8.30 (s, 0.2H, 2-Hminor), 8.40 (s, 0.8H, 2-Hmajor), 8.95
(s, 0.2H, NH minor), 9.29 (d, J " 4.0 Hz, 0.8H, NH major). 13C NMR
(DMSO!d6) d 15.3, 23.7, 33.9, 36.1, 59.8, 61.2, 73.3, 74.9, 76.8, 114.9,
117.2, 123.0, 124.6, 139.3, 147.1, 148.4, 148.5, 148.7, 150.1, 154.8, 156.1,
156.2. Anal. (C18H18F2N6O3.H2O) theoretical: C, 51.18; H, 4.77; N,




To a solution of 15a.2 (0.15 g, 0.31 mmol) in MeOH (3 mL), was
added HCl 12 N (1 mL). After 30 min at room temperature, meth-
anol was evaporated under reduced pressure and the resulting
residue was suspended in water (20 mL), neutralized with NaOH
10% and extracted with dichloromethane (3 $ 20 mL). The com-
bined organic layers were dried over MgSO4, concentrated under
reduced pressure and puri!ed by column chromatography on silica
gel using ethyl acetate 100% to give 7v as a white solid (0.11 g, 80%
yield, m.p.: 195e200 !C). 1H NMR (DMSO!d6) d 1.42e1.50 (m, 2H, 30-
H), 1.89 (m, 1H, 5000-Ha), 2.18 (ddd, J" 9.6 Hz/6.5 Hz/3.3 Hz, 0.7H, 20-
Hmajor), 2.29 (ddd, J" 9.6 Hz/6.4 Hz/3.2 Hz, 0.3H, 20-Hminor), 2.63
(m, 1H, 5000-Hb), 3.14 (m, 0.7H, 10-H major), 3.77 (m, 1H, 3000-H), 3.82
(m, 0.3H, 10-H minor), 3.94 (m, 1H, 1000-H), 4.56 (m, 0.3H, 2000-H mi-
nor), 4.61 (m, 0.7H, 2000-Hmajor), 4.96 (m, 2H, 3000-OH/4000-H), 5.05 (d,
J " 6.4 Hz, 0.3H, 2000-OH minor), 5.08 (d, J " 6.4 Hz, 0.7H, 2000-OH
major), 5.13 (d, J " 4.1 Hz, 0.3H, 1000-OH minor), 5.15 (d, J " 4.0 Hz,
0.7H, 1000-OHmajor), 7.04 (m, 0.3H, 600-Hminor), 7.14 (m, 0.7H, 600-H
major), 7.24e7.42 (m, 2H, 200-H/500-H), 9.53 (d, J " 5.0 Hz, 0.3H, NH
minor), 9.81 (d, J " 3.9 Hz, 0.7H, NH major). 13C NMR (DMSO!d6)
d 14.6, 23.7, 24.4, 33.6, 35.6, 36.1, 36.2, 61.0, 73.2, 75.1, 76.7, 114.9,
115.6, 117.1, 122.9, 123.5, 123.6, 124.0, 138.6, 147.2, 148.6, 150.0, 150.1,
151.7, 155.4, 156.6, 156.8, 157.6. Anal. (C18H17ClF2N6O3.H2O) theo-
retical: C, 47.32; H, 4.19; N, 18.40. Found: C, 47.51; H, 4.07; N, 18.08.
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4.63. (1S,2R,3S,4R)-4-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo
[4,5-d]pyrimidin-3-yl)cyclopentane-1,2,3-triol (7h)
To a solution of 16a (0.15 g, 0.41 mmol) in MeOH (3 mL), was
added HCl 12 N (1 mL). After 30 min at room temperature, meth-
anol was evaporated under reduced pressure and the resulting
residue was suspended in water (20 mL), neutralized with NaOH
10% and extracted with dichloromethane (3 $ 20 mL). The com-
bined organic layers were dried over MgSO4, concentrated under
reduced pressure and puri!ed by column chromatography on silica
gel using ethyl acetate/methanol gradient to give 7h as awhite solid
(0.05 g, 37% yield, m.p.: 175e180 !C). 1H NMR (DMSO!d6) d 0.99 (t,
J " 7.3 Hz, 3H, SCH2CH2CH3), 1.68 (h, J " 7.1 Hz, 2H, SCH2CH2CH3),
1.99 (ddd, J " 13.5 Hz/9.1 Hz/4.4 Hz, 1H, 50-Ha), 2.58 (ddd,
J " 13.7 Hz/9.1 Hz/7.2 Hz, 1H, 50-Hb), 3.08 (m, 2H, SCH2CH2CH3),
3.78 (m, 1H, 20-H), 3.93 (m, 1H, 10-H), 4.68 (m, 1H, 30-H), 4.96 (q,
J " 9.0 Hz, 1H, 40-H), 5.08 (bs, 3H, 1000-OH/2000-OH/3000-OH), 8.05 (bs,
1H, NHa), 8.40 (bs,1H, NHb). 13C NMR (CDCl3) d 13.3, 22.5, 32.1, 35.8,
61.2, 73.2, 74.3, 76.8, 122.8, 149.6, 155.1, 169.0. Anal.
(C12H18N6O3S.H2O) theoretical: C, 41.85; H, 5.85; N, 24.40. Found: C,




To a solution of 16b (0.15 g, 0.29 mmol) in MeOH (3 mL), was
added HCl 12 N (1 mL). After 30 min at room temperature, meth-
anol was evaporated under reduced pressure and the resulting
residue was suspended in water (20 mL), neutralized with NaOH
10% and extracted with dichloromethane (3 $ 20 mL). The com-
bined organic layers were dried over MgSO4, concentrated under
reduced pressure and puri!ed by column chromatography on silica
gel using ethyl acetate 100% to give 7i as a white solid (0.104 g, 75%
yield, m.p.: 60e65 !C). 1H NMR (DMSO!d6) d 0.81 (t, J" 7.4 Hz, 2.4H,
SCH2CH2CH3 major), 0.99 (t, J " 7.3 Hz, 0.6H, SCH2CH2CH3 minor),
1.38 (dq, J " 13.8 Hz/6.4 Hz, 1H, 30-Ha), 1.49 (tq, J " 13.6 Hz/6.9 Hz,
1.8H, SCH2CH2CH3 major/30-Hb minor), 1.56 (dt, J " 10.2 Hz/5.5 Hz,
0.8H, 30-Hb major), 1.68 (h, J " 7.1 Hz, 0.4H, SCH2CH2CH3 minor),
1.91 (ddd, J " 13.6 Hz/9.0 Hz/4.3 Hz, 1H, 5000-Ha), 2.13 (ddd,
J " 9.5 Hz/6.3 Hz/3.5 Hz, 0.8H, 20-H major), 2.25 (m, 0.2H, 20-H
minor), 2.59 (ddd, J " 13.7 Hz/9.1 Hz/7.3 Hz, 1H, 5000-Hb), 2.85 (dt,
J " 13.6 Hz/7.2 Hz, 0.8H, SCHa major), 2.95 (dt, J " 13.9 Hz/7.1 Hz,
0.8H, SCHb major), 3.09 (m, 0.4H, SCH 2 minor), 3.16 (m, 0.8H, 10-H
major), 3.78 (m, 1.2H, 10-H minor/2000-H), 3.93 (dt, J " 6.7 Hz/3.3 Hz,
1H, 1000-H), 4.65 (m, 1H, 3000-H), 4.91 (d, J " 3.9 Hz, 1H, 2000-OH), 4.95
(q, J " 9.0 Hz, 1H, 4000-H), 4.99 (d, J " 6.5 Hz, 0.2H, 3000-OH minor),
5.02 (d, J" 6.4 Hz, 0.8H, 3000-OHmajor), 5.07 (d, J" 3.8 Hz, 0.2H, 1000-
OHminor), 5.10 (d, J" 4.1 Hz, 0.8H,1000-OHmajor), 7.03 (bs, 0.2H, 600-
Hminor), 7.07 (bs, 0.8H, 600-Hmajor), 7.24e7.36 (m, 2H, 200-H/500-H),
8.93 (d, J " 4.7 Hz, 0.2H, NH minor), 9.35 (d, J " 4.0 Hz, 0.8H, NH
major). 13C NMR (DMSO!d6) d 13.0, 15.0, 22.3, 24.0, 32.3, 34.1, 36.0,
61.0, 73.2, 74.5, 76.8, 114.8, 117.0, 122.8, 123.1, 139.3, 147.1, 148.5,
149.4, 150.1, 153.9, 169.1. Anal. (C21H24F2N6O3S) theoretical: C,





To a solution of 16c (0.15 g, 0.37 mmol) in MeOH (3 mL), was
added HCl 12 N (1 mL). After 30 min at room temperature, meth-
anol was evaporated under reduced pressure and the resulting
residue was suspended in water (20 mL), neutralized with NaOH
10% and extracted with dichloromethane (3 $ 20 mL). The com-
bined organic layers were dried over MgSO4, concentrated under
reduced pressure and puri!ed by column chromatography on silica
gel using ethyl acetate/methanol gradient to give 7j as a white solid
(0.09 g, 66% yield, m.p.: 180e182 !C). 1H NMR (DMSO!d6) d 0.99 (t,
J " 7.3 Hz, 3H, SCH2CH2CH3), 1.69 (h, J " 7.2 Hz, 2H, SCH2CH2CH3),
2.06 (ddd, J " 14.3 Hz/9.8 Hz/5.0 Hz, 1H, 40-Ha), 2.63 (m, 1H, 40-Hb),
3.08 (m, 2H, SCH2CH2CH3), 3.46e3.52 (m, 4H, OCH2CH2OH), 3.76 (t,
J " 6.1 Hz, 1H, 50-H), 3.94 (m, 1H, 10-H), 4.60 (m, 2H, 20-H/OCH2-
CH2OH), 4.97 (q, J " 9.1 Hz, 1H, 30-H), 5.06 (d, J " 3.9 Hz, 1H, 10-OH),
5.13 (d, J" 6.4 Hz,1H, 20-OH), 8.07 (s, 1H, NHa), 8.42 (s,1H, NHb). 13C
NMR (DMSO!d6) d 13.3, 22.4, 32.1, 33.1, 60.3, 60.7, 70.8, 73.7, 74.1,
81.7, 122.8, 149.6, 155.1, 169.0. Anal. (C14H22N6O4S) theoretical: C,





To a solution of 16d (0.15 g, 0.33 mmol) in MeOH (3 mL), was
added HCl 12 N (1 mL). After 30 min at room temperature, meth-
anol was evaporated under reduced pressure and the resulting
residue was suspended in water (20 mL), neutralized with NaOH
10% and extracted with dichloromethane (3 $ 20 mL). The com-
bined organic layers were dried over MgSO4, concentrated under
reduced pressure and puri!ed by column chromatography on silica
gel using ethyl acetate/methanol gradient to give 7k as awhite solid
(0.09 g, 66% yield, m.p.: 156e158 !C). 1H NMR (DMSO!d6) d 0.69 (m,
2H, 20-Ha/30-Ha), 0.76 (m, 1.4H, 20-Hb major/30-Hb major), 0.87 (m,
0.6H, 20-Hb minor/30-Hb minor), 0.99 (t, J " 7.3 Hz, 3H,
SCH2CH2CH3), 1.71 (m, 2H, SCH2CH2CH3), 2.04 (ddd, J " 14.1 Hz/
9.8 Hz/5.0 Hz, 1H, 400-Ha), 2.65 (m, 1H, 400-Hb), 3.05 (m, 0.7H, 10-H
major), 3.12 (m, 2H, SCH2CH2CH3), 3.42e3.52 (m, 4.3H, 10-H minor/
OCH2CH2OH), 3.75 (m,1H, 500-H), 3.94 (m,1H,100-H), 4.56 (m,1H, 200-
H), 4.61 (m, 1H, OCH2CH2OH), 4.96 (m, 1H, 300-H), 5.06 (bs, 1H, 100-
OH), 5.13 (bs, 1H, 200-OH), 8.78 (d, J " 2.6 Hz, 0.3H, NH minor), 9.08
(d, J " 2.1 Hz, 0.7H, NH major). 13C NMR (DMSO!d6) d 5.9, 7.5, 13.3,
22.7, 23.7, 24.7, 26.1, 32.5, 33.2, 60.3, 61.5, 70.8, 73.6, 74.0, 74.3, 81.8,
123.1, 149.2, 154.1, 169.1. Anal. (C17H26N6O4S) theoretical: C, 49.74;




To a solution of 16e (0.15 g, 0.28 mmol) in MeOH (3 mL), was
added HCl 12 N (1 mL). After 30 min at room temperature, meth-
anol was evaporated under reduced pressure and the resulting
residue was suspended in water (20 mL), neutralized with NaOH
10% and extracted with dichloromethane (3 $ 20 mL). The com-
bined organic layers were dried over MgSO4, concentrated under
reduced pressure and puri!ed by column chromatography on silica
gel using ethyl acetate 100% to give 7l as a white solid (0.11 g, 79%
yield, m.p.: 174e179 !C). 1H NMR (DMSO!d6) d 0.80 (t, J " 7.4 Hz,
2.4H, SCH2CH2CH3 major), 0.99 (t, J " 7.3 Hz, 0.6H, SCH2CH2CH3
minor), 1.32 (m, 1H, 30-Ha), 1.40 (m, 0.2H, 30-Hb minor), 1.50 (m,
2.4H, 30-Hb major/SCH2CH2CH3 major), 1.69 (h, J " 7.1 Hz, 0.4H,
SCH2CH2CH3 minor), 2.04 (ddd, J " 14.1 Hz/9.7 Hz/5.0 Hz, 1H, 4000-
Ha), 2.12 (ddd, J " 9.5 Hz/6.3 Hz/3.3 Hz, 0.8H, 20-H major), 2.26 (m,
0.2H, 20-H minor), 2.63 (m, 1H, 4000-Hb), 2.88 (m, 1.6H, SCH2CH2CH3
major), 3.09 (m, 0.4H, SCH2CH2CH3 minor), 3.20 (dq, J " 7.9 Hz/
4.4 Hz, 0.8H, 10-H major), 3.45e3.53 (m, 4H, OCH2CH2OH), 3.75 (m,
1H, 5000-H), 3.85 (m, 0.2H, 10-H minor), 3.93 (m, 1H, 1000-H), 4.54 (m,
1H, 2000-H), 4.61 (t, J " 5.0 Hz, 1H, OCH2CH2OH), 4.96 (q, J " 9.1 Hz,
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1H, 3000-H), 5.05 (d, J" 4.1 Hz, 1H, 1000-OH), 5.12 (d, J" 6.4 Hz, 1H, 2000-
OH), 7.18 (m, 3H, 200-H/400-H/600-H), 7.29 (t, J " 7.6 Hz, 2H, 300-H/500-
H), 8.96 (d, J " 4.9 Hz, 0.2H, NHminor), 9.35 (d, J " 4.3 Hz, 0.8H, NH
major). 13C NMR (DMSO!d6) d 13.0, 15.0, 22.3, 24.5, 32.4, 33.2, 33.9,
60.3, 60.4, 70.8, 73.6, 74.4, 81.7, 123.1, 125.6, 125.9, 128.2, 141.2,
149.4, 153.8, 169.1. Anal. (C23H30N6O4S) theoretical: C, 56.77; H,




To a solution of 16f (0.15 g, 0.27 mmol) in MeOH (3 mL), was
added HCl 12 N (1 mL). After 30 min at room temperature, meth-
anol was evaporated under reduced pressure and the resulting
residue was suspended in water (20 mL), neutralized with NaOH
10% and extracted with dichloromethane (3 $ 20 mL). The com-
bined organic layers were dried over MgSO4, concentrated under
reduced pressure and puri!ed by column chromatography on silica
gel using ethyl acetate 100% to give 7m as a white solid (0.10 g, 72%
yield, m.p.: 137e142 !C). 1H NMR (DMSO!d6) d 0.97 (t, J" 7.3 Hz, 3H,
SCH2CH2CH3), 1.69 (h, J " 6.9 Hz, 2H, SCH2CH2CH3), 2.03 (ddd,
J " 14.0 Hz/9.7 Hz/4.9 Hz, 1H, 4000-Ha), 2.63 (m, 1H, 4000-Hb), 2.94 (t,
J " 7.1 Hz, 2H, 20-H2), 3.08 (m, 2H, SCH2CH2CH3), 3.45e3.52 (m, 4H,
OCH2CH2OH), 3.74 (m, 2.6H, 10-H2 major/5000-H), 3.94 (m, 1H, 1000-H),
4.10 (m, 0.4H, 10-H2 minor), 4.55 (m, 1H, 2000-H), 4.61 (t, J " 5.0 Hz,
1H, OCH2CH2OH), 4.96 (q, J " 9.2 Hz, 1H, 3000-H), 5.06 (d, J " 4.1 Hz,
1H, 1000-OH), 5.12 (d, J " 6.4 Hz, 1H, 2000-OH), 7.08 (m, 0.8H, 600-H
major), 7.17 (m, 0.2H, 600-H minor), 7.30e7.42 (m, 2H, 200-H/500-H),
8.70 (t, J " 6.4 Hz, 0.2H, NH minor), 9.06 (d, J " 5.6 Hz, 0.8H, NH
major). 13C NMR (DMSO!d6) d 13.3, 22.6, 32.4, 33.2, 33.5, 41.1, 60.2,
60.5, 70.8, 73.6, 74.3, 81.7, 117.1, 117.5, 123.0, 125.4, 137.1, 147.1, 148.2,
148.9, 149.3, 150.1, 150.6, 153.0, 169.0. Anal. (C22H28F2N6O4S) theo-
retical: C, 51.75; H, 5.53; N, 16.46; S, 6.28. Found: C, 51.35; H, 5.81;





To a solution of 16g (0.15 g, 0.27 mmol) in MeOH (3 mL), was
added HCl 12 N (1 mL). After 30 min at room temperature, meth-
anol was evaporated under reduced pressure and the resulting
residue was suspended in water (20 mL), neutralized with NaOH
10% and extracted with dichloromethane (3 $ 20 mL). The com-
bined organic layers were dried over MgSO4, concentrated under
reduced pressure and puri!ed by column chromatography on silica
gel using ethyl acetate 100% to give 1 as a white solid (0.115 g, 83%
yield, m.p.: 135e138 !C). 1H NMR (DMSO!d6) d 0.82 (t, J " 7.3 Hz,
2.4H, SCH2CH2CH3 major), 0.99 (t, J " 7.3 Hz, 0.6H, SCH2CH2CH3
minor), 1.37 (m, 1H, 30-Ha), 1.46 (m, 0.2H, 30-Hb minor), 1.50 (ddt,
J " 11.5 Hz/7.1 Hz/4.4 Hz, 1.6H, SCH2CH2CH3 major), 1.55 (dt,
J " 10.3 Hz/5.4 Hz, 0.8H, 30-Hb major), 1.69 (h, J " 6.9 Hz, 0.4H,
SCH2CH2CH3 minor), 2.03 (m, 1H, 4000-Ha), 2.12 (m, 0.8H, 20-H ma-
jor), 2.25 (m, 0.2H, 20-H minor), 2.63 (m, 1H, 4000-Hb), 2.85 (dt,
J " 13.6 Hz/7.2 Hz, 0.8H, SCHa major), 2.94 (dt, J " 13.9 Hz/7.1 Hz,
0.8H, SCHb major), 3.08 (m, 0.4H, SCH 2 minor), 3.16 (m, 0.8H, 10-H
major), 3.44e3.52 (m, 4H, OCH2CH2OH), 3.76 (t, J " 5.2 Hz, 1H, 5000-
H), 3.79 (m, 0.2H, 10-H minor), 3.94 (m, 1H, 1000-H), 4.56 (dt,
J " 8.7 Hz/6.0 Hz, 1H, 2000-H), 4.60 (t, J " 4.9 Hz, 1H, OCH2CH2OH),
4.96 (q, 9.1 Hz, 1H, 3000-H), 5.05 (d, J " 4.0 Hz, 1H, 1000-OH), 5.12 (m,
1H, 2000-OH), 7.04 (bs, 0.2H, 600-Hminor), 7.07 (bs, 0.8H, 600-Hmajor),
7.23e7.37 (m, 2H, 200-H/500-H), 8.94 (d, J " 4.6 Hz, 0.2H, NH minor),
9.36 (d, J" 3.6 Hz, 0.8H, NHmajor). 13C NMR (DMSO!d6) d 13.0, 15.0,
22.3, 24.0, 32.3, 33.2, 34.1, 60.3, 60.5, 70.8, 73.7, 74.3, 81.8, 114.8,
117.0, 122.8, 123.2, 139.3, 146.8, 148.4, 148.7, 149.4, 150.3, 150.8,
154.0, 169.2. Anal. (C23H28F2N6O4S) theoretical: C, 52.86; H, 5.40; N,
16.08; S, 6.13. Found: C, 52.75; H, 5.75; N, 16.06, S, 6.26.
4.70. (1S,2R,3S,4R)-4-(7-amino-5-((2-hydroxypropyl)thio)-3H-
[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2,3-triol (7n)
To a solution of 16h (0.15 g, 0.39 mmol) in MeOH (3 mL), was
added HCl 12 N (1 mL). After 30 min at room temperature, meth-
anol was evaporated under reduced pressure and the resulting
residue was suspended in water (20 mL), neutralized with NaOH
10% and extracted with dichloromethane (3 $ 20 mL). The com-
bined organic layers were dried over MgSO4, concentrated under
reduced pressure and puri!ed by column chromatography on silica
gel using ethyl acetate/methanol gradient to give 7n as awhite solid
(0.07 g, 52% yield, m.p.: 177e180 !C). 1H NMR (DMSO!d6) d 1.16 (d,
J " 5.7 Hz, 3H, CH3), 1.94 (ddt, J " 13.2 Hz/8.5 Hz/4.1 Hz, 1H, 50-Ha),
2.57 (m, 1H, 50-Hb), 3.17 (m, 2H, SCH 2), 3.78 (bs, 1H, 20-H), 3.87 (m,
1H, SCH2CHOH), 3.93 (m, 1H, 10-H), 4.67 (m, 1H, 30-H), 4.85 (d,
J " 4.6 Hz, 0.5H, S-SCH2CHOH), 4.87 (d, J " 4.8 Hz, 0.5H,
ReSCH2CHOH), 4.95e4.98 (m, 2H, 20-OH/40-H), 5.04 (bs, 1H, 30-OH),
5.17 (d, J" 3.3 Hz,1H,10-OH), 8.07 (s, 1H, NHa), 8.42 (s, 1H, NHb). 13C
NMR (DMSO!d6) d 22.6, 35.7, 38.8, 61.1, 65.4, 73.1, 74.3, 76.7, 122.8,
149.5,155.1,169.1. Anal. (C12H18N6O4S) theoretical: C, 42.10; H, 5.30;
N, 24.55; S, 9.37. Found: C, 42.17; H, 5.56; N, 24.47, S, 9.39.
4.71. (1S,2R,3S,4R)-4-(7-amino-5-((3-hydroxypropyl)thio)-3H-
[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2,3-triol (7o)
To a solution of 16i (0.15 g, 0.33 mmol) in MeOH (3 mL), was
added HCl 12 N (1 mL). After 30 min at room temperature, meth-
anol was evaporated under reduced pressure and the resulting
residue was suspended in water (20 mL), neutralized with NaOH
10% and extracted with dichloromethane (3 $ 20 mL). The com-
bined organic layers were dried over MgSO4, concentrated under
reduced pressure and puri!ed by column chromatography on silica
gel using ethyl acetate/methanol gradient to give 7o as awhite solid
(0.08 g, 59% yield, m.p.: 185e187 !C). 1H NMR (DMSO!d6) d 1.82 (m,
2H, SCH2CH2CH2OH), 1.94 (m, 1H, 50-Ha), 2.59 (m, 1H, 50-Hb), 3.14
(m, 2H, SCH2CH2CH2OH), 3.52 (SCH2CH2CH2OH), 3.79 (m, 1H, 20-H),
3.94 (m, 1H, 10-H), 4.52 (m, 1H, SCH2CH2CH2OH), 4.67 (m, 1H, 30-H),
4.91 (m, 1H, 20-OH), 4.96 (d, J " 8.4 Hz, 1H, 40-H), 5.02 (m, 1H, 30-
OH), 5.10 (m, 1H, 10-OH), 8.04 (s, 1H, NHa), 8.40 (s, 1H, NHb). 13C
NMR (DMSO!d6) d 27.1, 32.2, 35.9, 59.4, 61.1, 73.1, 74.4, 76.7, 122.8,
149.6, 155.1, 169.0. Anal. (C12H18N6O4S) theoretical: C, 42.10; H,




To a solution of 16j (0.15 g, 0.28 mmol) in MeOH (3 mL), was
added HCl 12 N (1 mL). After 30 min at room temperature, meth-
anol was evaporated under reduced pressure and the resulting
residue was suspended in water (20 mL), neutralized with NaOH
10% and extracted with dichloromethane (3 $ 20 mL). The com-
bined organic layers were dried over MgSO4, concentrated under
reduced pressure and puri!ed by column chromatography on silica
gel using ethyl acetate/methanol gradient to give 7p as awhite solid
(0.11 g, 79% yield, m.p.: 147e149 !C). 1H NMR (DMSO!d6) d 1.37 (q,
J" 6.4 Hz, 0.8H, 30-Hamajor), 1.40 (q, J" 6.7 Hz, 0.2H, 30-Haminor),
1.46 (m, 0.2H, 30-Hbminor), 1.52 (dt, J " 10.0 Hz/5.3 Hz, 0.8H, 30-Hb
major), 1.66 (p, J " 6.6 Hz, 1.6H, SCH2CH2CH2OH major), 1.81 (p,
J " 6.3 Hz, 0.4H, SCH2CH2CH2OH minor), 1.91 (ddd, J " 13.3 Hz/
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9.0 Hz/4.2 Hz, 1H, 5000-Ha), 2.14 (m, 0.8H, 20-Hmajor), 2.25 (m, 0.2H,
20-H minor), 2.59 (m, 1H, 5000-Hb), 2.95 (dt, J " 13.7 Hz/7.1 Hz, 0.8H,
SCHamajor), 3.02 (dt, J" 13.8 Hz/7.0 Hz, 0.8H, SCHbmajor), 3.16 (m,
1.2H, SCH 2 minor/10-H major), 3.38 (q, J " 5.9 Hz, 1.6H,
SCH2CH2CH2OH major), 3.52 (q, J " 5.5 Hz, 0.4H, SCH2CH2CH2OH
minor), 3.78 (m, 1.2H, 10-Hminor/2000-H), 3.93 (m, 1H, 1000-H), 4.47 (t,
J " 5.1 Hz, 0.8H, SCH2CH2CH2OH major), 4.53 (t, J " 4.8 Hz, 0.2H,
SCH2CH2CH2OH minor), 4.65 (m, 1H, 3000-H), 4.92 (d, J " 3.8 Hz, 1H,
2000-OH), 4.95 (q, J " 9.0 Hz, 1H, 4000-H), 5.00 (d, J " 6.5 Hz, 0.2H, 3000-
OH minor), 5.02 (d, J " 6.4 Hz, 0.8H, 3000-OH major), 5.09 (d,
J " 3.8 Hz, 0.2H, 1000-OH minor), 5.11 (d, J " 4.0 Hz, 0.8H, 1000-OH
major), 7.03 (bs, 0.2H, 600-H minor), 7.07 (bs, 0.8H, 600-H major),
7.24e7.35 (m, 2H, 200-H/500-H), 8.94 (d, J " 4.5 Hz, 0.2H, NH minor),
9.34 (d, J" 3.7 Hz, 0.8H, NHmajor). 13C NMR (DMSO!d6) d 15.1, 23.9,
27.2, 32.2, 33.9, 36.0, 59.2, 61.0, 73.2, 74.5, 76.7, 114.8, 117.0, 122.8,
123.1, 139.2, 147.0, 148.4, 149.3, 150.0, 153.9, 169.1. Anal.
(C21H24F2N6O4S) theoretical: C, 51.00; H, 4.89; N, 16.99; S, 6.48.




To a solution of 16k (0.15 g, 0.28 mmol) in MeOH (3 mL), was
added HCl 12 N (1 mL). After 30 min at room temperature, meth-
anol was evaporated under reduced pressure and the resulting
residue was suspended in water (20 mL), neutralized with NaOH
10% and extracted with dichloromethane (3 $ 20 mL). The com-
bined organic layers were dried over MgSO4, concentrated under
reduced pressure and puri!ed by column chromatography on silica
gel using ethyl acetate/methanol gradient to give 7q as awhite solid
(0.09 g, 65% yield, m.p.: 90 !C dec.). 1H NMR (DMSO!d6) d 1.00 (d,
J " 6.0 Hz, 2.4H, CH3 major), 1.17 (d, J " 6.9 Hz, 0.6H, CH3 minor),
1.38 (m,1H, 30-Ha), 1.46 (m, 0.2H, 30-Hbminor), 1.53 (m, 0.8H, 30-Hb
major), 1.92 (ddd, J " 13.3 Hz/8.9 Hz/4.1 Hz, 1H, 5000-Ha), 2.13 (m,
0.8H, 20-H major), 2.25 (m, 0.2H, 20-H minor), 2.60 (m, 1H, 5000-Hb),
2.89 (dd, J " 13.4 Hz/6.8 Hz, 0.8H, SCHa major), 3.14 (m, 1.8H, SCHa
minor/SCHb major/10-H major), 3.21 (dd, J " 13.5 Hz/5.2 Hz, 0.2H,
SCHb minor), 3.72e3.78 (m, 2H, SCH2CHOH major/10-H minor/2000-
H), 3.87 (m, 0.2H, SCH2CHOH minor), 3.93 (m, 1H, 1000-H), 4.66 (q,
J " 6.3 Hz, 1H, 3000-H), 4.80 (d, J " 4.8 Hz, 0.8H, SCH2CHOH major),
4.87 (d, J " 4.5 Hz, 0.2H, SCH2CHOH minor), 4.95 (d, J " 4.3 Hz, 1H,
2000-OH), 4.98 (m,1.2H, 4000-H/3000-OHminor), 5.04 (d, J" 6.4 Hz, 0.8H,
3000-OH major), 5.17 (d, J " 3.7 Hz, 1H, 1000-OH), 7.04 (bs, 0.2H, 600-H
minor), 7.09 (bs, 0.8H, 600-H major), 7.24e7.37 (m, 2H, 200-H/500-H),
8.96 (d, J " 4.4 Hz, 0.2H, NH minor), 9.36 (d, J " 3.9 Hz, 0.8H, NH
major). 13C NMR (DMSO!d6) d 15.0, 22.4, 24.0, 33.9, 35.9, 39.6, 61.1,
65.2, 73.2, 74.5, 76.7, 114.9, 117.0, 122.9, 123.1, 139.2, 147.1, 148.4,
148.7, 149.2, 150.1, 153.9, 169.2. Anal. (C21H24F2N6O4S) theoretical:





To a solution of 16l (0.15 g, 0.28 mmol) in MeOH (3 mL), was
added HCl 12 N (1 mL). After 30 min at room temperature, meth-
anol was evaporated under reduced pressure and the resulting
residue was suspended in water (20 mL), neutralized with NaOH
10% and extracted with dichloromethane (3 $ 20 mL). The com-
bined organic layers were dried over MgSO4, concentrated under
reduced pressure and puri!ed by column chromatography on silica
gel using ethyl acetate/methanol gradient to give 7r as awhite solid
(0.10 g, 72% yield, m.p.: 90 !C dec.). 1H NMR (DMSO!d6) d 1.02 (d,
J" 6.1 Hz, 2.4H, CH3major),1.17 (d, J" 6.0 Hz, 0.6H, CH3minor),1.38
(m, 1H, 30-Ha), 1.46 (m, 0.2H, 30-Hb minor), 1.52 (m, 0.8H, 30-Hb
major), 1.92 (m, 1H, 5000-Ha), 2.15 (m, 0.8H, 20-H major), 2.25 (m,
0.2H, 20-Hminor), 2.60 (m, 1H, 5000-Hb), 3.06 (m, 1.6H, SCH 2 major),
3.18 (m, 1.2H, 10-H major/SCH 2 minor), 3.73e3.78 (m, 2H,
SCH2CHOH major/10-H minor/2000-H), 3.88 (m, 0.2H, SCH2CHOH
minor), 3.93 (m, 1H, 1000-H), 4.66 (m, 1H, 3000-H), 4.76 (d, J " 4.7 Hz,
0.8H, SCH2CHOH major), 4.84 (d, 4.5 Hz, 0.2H, SCH2CHOH minor),
4.93 (d, J" 3.8 Hz,1H, 2000-OH), 4.96 (q, J" 9.0 Hz,1H, 4000-H), 4.99 (d,
J " 6.5 Hz, 0.2H, 3000-OH minor), 5.02 (d, J " 6.4 Hz, 0.8H, 3000-OH
major), 5.16 (d, J " 4.0 Hz, 1H, 1000-OH), 7.04 (bs, 0.2H, 600-H minor),
7.09 (bs, 0.8H, 600-H major), 7.24e7.35 (m, 2H, 200-H/500-H), 8.94 (d,
J " 4.4 Hz, 0.2H, NHminor), 9.33 (d, J " 3.9 Hz, 0.8H, NHmajor). 13C
NMR (DMSO!d6) d 15.1, 22.4, 23.9, 33.8, 36.0, 39.1, 61.0, 65.2, 73.2,
74.5, 76.8, 114.9, 117.0, 122.9, 123.1, 139.2, 147.1, 148.7, 149.2, 153.8,
169.3. Anal. (C21H24F2N6O4S.H2O) theoretical: C, 49.21; H, 5.11; N,





To a solution of 16m (0.15 g, 0.26 mmol) in MeOH (3 mL), was
added HCl 12 N (1 mL). After 30 min at room temperature, meth-
anol was evaporated under reduced pressure and the resulting
residue was suspended in water (20 mL), neutralized with NaOH
10% and extracted with dichloromethane (3 $ 20 mL). The com-
bined organic layers were dried over MgSO4, concentrated under
reduced pressure and puri!ed by column chromatography on silica
gel using ethyl acetate/methanol gradient to give 7s as awhite solid
(0.12 g, 86% yield, m.p.: 148e153 !C). 1H NMR (DMSO!d6) d 1.00 (d,
J" 6.2 Hz,1.2H, CH3major R or S), 1.02 (d, J" 6.2 Hz,1.2H, CH3major
R or S), 1.17 (d, J " 7.1 Hz, 0.6H, CH3 minor), 1.38 (m, 1H, 30-Ha), 1.47
(m, 0.2H, 30-Hb minor), 1.53 (m, 0.8H, 30-Hb major), 2.02 (ddt,
J " 14.0 Hz/9.3 Hz/4.4 Hz, 1H, 4000-Ha), 2.14 (m, 0.8H, 20-H major),
2.25 (m, 0.2H, 20-H minor), 2.64 (m, 1H, 4000-Hb), 2.86 (dd,
J " 13.4 Hz/7.0 Hz, 0.4H, SCHa major R or S), 3.05 (d, J " 5.8 Hz, 1H,
SCHb major), 3.13e3.19 (m, 1.6H, SCHa major R or S, SCHa minor,
SCHb minor, 10-H), 3.46e3.52 (m, 4H, OCH2CH2OH), 3.74 (m, 1.8H,
SCH2CHOHmajor/5000-H), 3.88 (m, 0.2H, SCH2CHOHminor), 3.95 (m,
1H, 1000-H), 4.56 (m, 1H, 2000-H), 4.61 (t, J " 4.9 Hz, OCH2CH2OH), 4.78
(m, 0.8H, SCH2CHOHmajor), 4.86 (m, 0.8H, SCH2CHOHminor), 4.96
(q, J " 8.7 Hz, 1H, 3000-H), 5.06 (d, J " 3.8 Hz, 1H, 1000-OH), 5.09e5.12
(m, 1H, 2000-OH), 7.03 (m, 0.2H, 600-H minor), 7.09 (m, 0.8H, 600-H),
7.24e7.36 (m, 2H, 200-H/500-H), 8.96 (d, J " 4.5 Hz, 0.2H, NH minor),
9.35 (m, 0.8H, NH major). 13C NMR (DMSO!d6) d 15.1, 22.5, 24.0,
33.3, 33.9, 35.7, 39.4, 60.3, 60.5, 65.2, 70.9, 73.7, 74.4, 81.8, 114.9,
117.0, 122.9, 123.1, 139.2, 147.1, 148.5, 148.7, 149.4, 150.1, 153.9, 169.4.
Anal. (C23H28F2N6O5S) theoretical: C, 51.29; H, 5.24; N, 15.60; S,





To a solution of 16n (0.15 g, 0.26 mmol) in MeOH (3 mL), was
added HCl 12 N (1 mL). After 30 min at room temperature, meth-
anol was evaporated under reduced pressure and the resulting
residue was suspended in water (20 mL), neutralized with NaOH
10% and extracted with dichloromethane (3 $ 20 mL). The com-
bined organic layers were dried over MgSO4, concentrated under
reduced pressure and puri!ed by column chromatography on silica
gel using ethyl acetate/methanol gradient to give 7t as awhite solid
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(0.10 g, 72% yield, m.p.: 135e137.5 !C). 1H NMR (DMSO!d6) d 1.38 (q,
J " 6.1 Hz, 0.8H, 30-Ha major), 1.40 (m, 0.2H, 30-Ha minor), 1.46 (dt,
J " 9.9 Hz/5.3 Hz, 0.2H, 30-Hb minor), 1.53 (dt, J " 11.0 Hz/5.5 Hz,
0.8H, 30-Hbmajor), 1.66 (p, J " 6.7 Hz, 1.6H, SCH2CH2CH2OH major),
1.81 (p, J " 6.6 Hz, 0.4H, SCH2CH2CH2OH minor), 2.02 (ddd,
J " 14.0 Hz/9.7 Hz/5.0 Hz, 1H, 4000-Ha), 2.14 (ddd, J " 9.5 Hz/6.4 Hz/
3.3 Hz, 0.8H, 20-H major), 2.25 (m, 0.2H, 20-H minor), 2.64 (m, 1H,
4000-Hb), 2.93e3.03 (m, 1.6H, SCH2CH2CH2OH major), 3.15e3.18 (m,
1.2H, SCH2CH2CH2OH minor/10-H major), 3.38 (q, J " 6.1 Hz, 1.6H,
SCH2CH2CH2OH major), 3.46e3.53 (m, 4.4H, SCH2CH2CH2OH mi-
nor/OCH2CH2OH), 3.76 (m, 1H, 5000-H), 3.79 (m, 0.2H, 10-H minor),
3.94 (m, 1H, 1000-H), 4.47 (t, J " 5.2 Hz, 0.8H, SCH2CH2CH2OHmajor),
4.55 (m, 1.2H, SCH2CH2CH2OH minor/2000-H), 4.61 (t, J " 5.2 Hz, 1H,
OCH2CH2OH), 4.96 (q, J " 9.1 Hz, 1H, 3000-H), 5.05 (d, J " 4.1 Hz, 1H,
1000-OH), 5.09 (d, J " 6.5 Hz, 0.8H, 2000-OH major), 5.12 (d, J " 6.4 Hz,
0.2H, 2000-OHminor), 7.03 (m, 0.2H, 600-Hminor), 7.07 (m, 0.8H, 600-H
major), 7.24e7.35 (m, 2H, 200-H/500-H), 8.95 (d, J " 4.8 Hz, 0.2H, NH
minor), 9.35 (d, J " 4.0 Hz, 0.8H, NH major). 13C NMR (DMSO!d6)
d 15.1, 23.9, 27.3, 32.1, 33.3, 33.9, 59.2, 60.3, 60.5, 70.9, 73.7, 74.4,
81.8, 115.0, 117.1, 122.8, 123.1, 139.2, 147.1, 148.4, 148.7, 149.4, 150.1,
153.9, 169.2. Anal. (C23H28F2N6O5S) theoretical: C, 51.29; H, 5.24; N,
15.60; S, 5.95. Found: C, 50.89; H, 5.29; N, 15.51, S, 5.99.
4.77. Biological evaluation
4.77.1. Antiplatelet activity
4.77.1.1. Platelet rich plasma (PRP) preparation. Venous blood was
obtained from healthy volunteers (between 20 and 40 years old)
who had not taken any drugs or medications for at least 10 days.
Procedureswere approved by the institutional review committee of
the Universtisty of Liege (Comit!e d’!ethique hospital-facultaire
universitaire de liege). Blood samples were collected into citrate
tubes (3.2% citrate, Greiner-BioOne) and processed within 30 min
after collection. Platelet-rich-plasma (PRP) was separated by
centrifugation of anticoagulated whole blood at 100$g for
15 min at room temperature. Platelet count was measured using a
hematology analyser (Cell-dyn 3700, Abbott). Platelet poor plasma
(PPP) was obtained by centrifugation of whole blood at 800$g for
15 min. The platelet count in PRP was then adjusted to 250000/ml
by diluting PRP with autologous PPP.
4.77.1.2. Platelet aggregation. Platelet aggregation assays were
performed with PRP under stirring (1200 rpm) at 37 !C on a
Chrono-Log Lumi-aggregometer (Kordia). PRP was pre-incubated
with ticagrelor or its analogues (1.8 mM) for 10 min prior to stir-
ring and addition of ADP (10 mM). Platelet aggregation was moni-
tored for 10 min. The area under the curve (AUC) was recorded.
Results were expressed as fold-inhibition vs. vehicle (1% DMSO).
Data are presented as mean ± S.D. obtained from 4 to 21 healthy
volunteers (age: 29 (3), median (IQR); 67% males). AUC values
recorded in the presence of test molecules were compared to the
values obtained with the vehicle control (1% DMSO) or with the
reference molecule 1 (ticagrelor) by using the non-parametric
Wilcoxon signed rank test for paired samples (Prism version
8.1.2). P < 0.05 was considered signi!cant.
4.77.2. Antibacterial activity
A single colony of S.aureus (MRSA, BAA-1556) grown on a Brain
Heart Infusion Agar plate was resupended and cultured in Brain
Heart infusion broth medium (BHI) overnight (O/N) under aerobic
conditions (37 !C, 190 rpm shaking). On the next day, the resulting
inoculum was diluted 100 times in Mueller-Hinton broth (MHB)
and incubated in aerobic conditions to reach a growth exponential
phase. The resulting inoculum corresponding to about 5.105 colony
forming units (CFU)/ml was further incubated in the presence or in
the absence of different concentrations of the testedmolecules. The
vehicle was 1% DMSO. The bacterial growth in culture media was
evaluated by measuring the optical density (OD) at 600 nm (OD600)
by use of a spectrophotometer. The Minimal Inhibitory Concen-
tration (MIC) of each molecule tested was determined according to
the EUCAST guidelines. The MIC represents the concentration at
which there is no visible growth, i.e DOD at 600 nm is equal to zero
wherein DOD is the difference between the resulting OD in the
presence of the molecule and the OD of the blank (blank is the
medium with 1% DMSO).
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